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ABSTRACT 
From its humble beginnings as a novel carbon–carbon bond forming reaction, the 
Pauson–Khand reaction has lead to the synthetic development of a variety of natural products. 
One particular variation of the Pauson–Khand reaction was called the hetero Pauson–Khand.  
This reaction differs from the normal Pauson–Khand reaction because the reaction employs an 
intramolecular titanium mediated cycloaddition using enal and enones instead of alkenes and 
alkynes functional groups to prepare a variety of natural products.  These natural products 
usually contain a bicyclic cyclopentenone core.  Because the new ring contains a hetero atom, 
the name hetero Pauson–Khand was coined. 
α–Methylene–γ–Butyrolactones posses a wide range of biological activities.  These 
activities range from antibacterial to anti–inflammatory and make these lactones interesting 
targets for synthetic groups to produce in labs.  In an attempt to expand our knowledge of 
titanium chemistry, α–methylene–γ–butyrolactones syntheses were investigated using titanium 
catalyzed hetero Pauson–Khand reaction.  Several substituted titanacene metallacycles were 
produced in good to excellent yields since the carbon monoxide insertion under pressure proved 
problematic. 
Because of its importance to the perfume industry; many synthetic groups have 
synthesized methyl jasmonate.  Methyl jasmonate was synthesized from 3–(tert–Butyl–
dimethyl–silanyloxy)–propionaldehyde and 5–Bromo–penta–1,3–diene using the hetero Pauson–
Khand reaction in twelve steps.    Methyl jasmonate was converted from jasmonic acid in 60 % 
yield as clear oil. 
In an effort to circumvent the problems associated with synthesizing α–methylene–γ–
butyrolactones from the hetero Pauson–Khand reaction; isonitrile insertions into allenals and 
allenones were investigated.  If successful, these iminocyclopentanones would have been 
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hydrolyzed to the corresponding α–methylene–γ–butyrolactones.    Initial titanacene macrocycles 
formed, but the desired iminocyclopentanones intermediates were never produced. 
 1
CHAPTER 1 
THE HISTORY OF THE PAUSON–KHAND REACTION FROM ITS INTRODUCTION 




The first Pauson–Khand reaction was done by Peter L. Pauson, Ishan U. Khand and co–
workers in 1973.1,2    The Pauson–Khand reaction is a [2+2+1] cycloaddition.    The first reaction 
used an alkyne–dicobalt hexacarbonyl complex and norbornadiene to produce a cyclopentenone 







Scheme 1.1. The first Pauson–Khand reaction. 
 













Figure 1.1. Other products made from the reaction. 
 
Several reviews for the Pauson-Khand reaction have been published.3-6  
 
1.2. Intramolecular Pauson–Khand Reaction 
 
The intramolecular PK reaction was done by Schore and coworkers.7    This reaction used 
an α, ω–enynes with Co2(CO)8 in trimethyl pentane to produce the desired bicyclic–






95 0C, 4 days
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Scheme 1.2. An intramolecular Pauson–Khand reaction. 
1.3. Proposed Pauson–Khand Reaction Mechanism 
Since it is difficult to isolate intermediates in the Pauson–Khand reaction; the mechanism 
of the Pauson–Khand reaction is not clearly known, but a mechanism was proposed.8    The loss 
of two carbonyl ligands, CO, from dicobalt octacarbonyl complex, Co2CO8, is followed by the 











- CO + H2C CH2






































































Scheme 1.3. Proposed mechanism for the Pauson–Khand reaction. 
One more carbonyl ligand, CO, is disassociated from the complex and an alkene is added.    
Another CO ligand adds to the complex after the alkene insertion which opens a vacant site.    
Then another CO adds to the complex after a CO is inserted to open up an empty site for the 
addition.    The subsequent reductive elimination to produce the cyclopentenone and the 
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generation of the dicobalt hexacarbonyl complex illustrates a possible mechanism for the 
Pauson–Khand reaction (Scheme 1.3).    What is of interest here is that without the migratory 
insertion from the alkene; there would be no addition of CO ligands. 
1.4. N–Oxide Promoters 
 
It was discovered that N–methylmorpholine–N–oxide, NMO, can be used to accelerate 
intramolecular PK reactions at room temperature under argon or nitrogen.9    Scheme 1.4 shows 






















H H  
Scheme 1.4. NMO promoted Pauson–Khand reaction. 
The only limitation to this procedure is that electron deficient alkyne substrates on the enyne 
failed to cyclize and produced the desired bicyclic cyclopentenone.    Instead, it produced a 










R = TBS  
 
Scheme 1.5. NMO promoted intramolecular Pauson–Khand reaction using electron deficient 
alkynes. 
The likely mechanism for the NMO accelerated reaction used the initial oxidation of the CO 
ligand to CO2.    This process creates a vacant site on the cobalt complex. 
1.5. Sulfide Promoters of PK Reaction 
A variety of alkyl methyl sulfides were used to promote the PK reactions.    n–Butyl 
methyl sulfides, n–BuSMe, were discovered to accelerate the stoiciometric PK reaction the 
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best.10    When n–BuSMe used instead of an amine promoted Pauson–Khand reaction; cleavage 
of the “carbon–heteroatom” bond was not observed.    The advantages of using a dialkyl sulfide 














83 0C, 30 min.
99 %
 
Scheme 1.6. Advantages of utilizing a sulfide promoted Pauson–Khand reaction over a NMO 
reaction. 
 
They discovered that n–BuSMe promote the intramolecular cyclization of the PK reaction using 











Scheme 1.7. Sulfide promoted Pauson–Khand reaction. 
 
1.6. Catalytic PK Reactions 
Rautenstrauch and coworkers accomplished a catalytic intermolecular PK reaction using 
Co2(CO)8, an unstrained alkene, an alkyne and CO.11    A catalytic intramolecular version was 
previously reported by Pauson and co-workers.2    Rautenstrauch’s experiment involved utilizing 
 5
a 0.80 M toluene solution of 1-heptyne, 0.22 mol % of [Co2(CO)8], 40 bar of ethylene and 100 
bar CO.    The reaction mixture was heated to 150 0C and stirred for 16 h and produced 2-
pentylcyclopent-2-en-1-one in a 47–49 % yield.  
Livinghouse and coworkers discovered that they could use heat to promote an 
intramolecular PK reaction using Co2(CO)8 (Scheme 1.8).    The reaction involved using an 











5 mol % Co2(CO)8




DME = dimethoxy ethane
E = CO2CH3  
Scheme 1.8. The first PK reaction done using catalytic amounts of Co2(CO)8. 
 
Livinghouse discovered that Co2(CO)6–alkyne complexes are generated from Co2(CO)8 and 2–
methyl–3–butyn–2–ol or phenyl–ethyne (Scheme 1.9).    Livinghouse reported that Co2(CO)6–
alkyne complexes can replace Co2(CO)8 in thermal catalytic PK reactions and they 
observed“significant” increase in the percent yield when CyNH2 was present in the PK 
reactions.13 
1.7. Metals Other Than Cobalt Used in PK Reaction 
Besides cobalt, many other transition metals can be used to facilitate the Pauson–Khand 
reaction.    These other transition metals were the first to be employed toward the Pauson–Khand 
reaction. 
1.7.1. Zirconium Transition Metal Complex 
Negishi and coworkers reported synthesizing bicyclic ketones from trialkylsilyl enynes 
and a Cp2ZrCl2 complex using an intramolecular PK reaction (Scheme 1.10).    This reaction was 
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done stoichiometrically with a 1:1 ratio of the zirconium transition metal complex and the vinyl–
silyl–enynes.14    These α–silyl cyclopentanones were made in moderate to good yields.    














5 mol % 1,2-DME
Et3SiH





65 0C, 12 h
CO (1atm.)
95 %
Cy = Cyclohexyl -




















n = 3 or 4  
Scheme 1.10. An intramolecular Pauson–Khand reaction using a zirconium transition metal 
complex. 
 
1.7.2. Nickel Transition Metal Complex 
Tamao and reported utilizing a Ni(0) complex, enynes, and isocyanides to produce 1–
imino–2–cyclopentenes in moderate to good yields (Scheme 1.11).    The 1–imino–2–
cyclopentenes could later be hydrolyzed into cyclopentenones.15    These cyclopentanones were 
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made in good to excellent yields and it showed that nickel complexes can be employed to make 





















40-44 %  
Scheme 1.11. Synthesis of cyclopentenones using a Nickel transition metal complex. 
 
1.7.3. Molybdenum Transition Metal Complex 
Hanaoka and coworkers used a molybdenum–alkyne complex to synthesize both 3–
substituted and 2–substituted cyclopentenones utilizing an intermolecular PK reaction.    What 
makes this procedure interesting is that both 2 and 3–substituted cyclopentenones (A & B) were 
both isolated in poor to moderate yields for the first time (Scheme 1.12).    One of the problems 
with this intermolecular PK reaction is that regioselectivity cannot be controlled and the yields of 












A = 45 %




M = Mo2Cp2(CO)4  
Scheme 1.12. An intermolecular Pauson–Khand reaction using a molybdenum transition metal 
complex. 
 
The molybdenum complex was also used for an intramolecular PK reaction to synthesize a 
bicyclic ketone (Scheme 1.13).16    The bicyclic cyclopentenone produced in this reaction was 
 8
made in moderate yields.    The molybdenum–alkyne complex that is used for the PK reactions 










M = Mo2Cp2(CO)4  
Scheme 1.13. An intramolecular Pauson–Khand reaction using a molybdenum metal complex. 
 
1.7.4. Titanium Transition Metal Complex 
Buchwald and coworkers were the first to use titanium complexes to create bicyclic 
cyclopentenones hydrolyzed from iminocyclopentenones (Scheme 1.14).17    This reaction 
incorporated the use of Cp2Ti(PMe3)2 catalytically with a CO insertion and substituted enynes to 























X = O, NPh
R' = t-BuMe2Si
R'CN = t-BuMe2SiCN  
Scheme 1.14. Cyclopentanones synthesis using a titanium metal complex. 
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1.7.5. Iron Transition Metal Complex 
Pearson and coworkers were the first to use an iron carbonyl complex to do an 
intramolecular Pauson–Khand cycloaddition on enyne and diyne substrates (Scheme 1.15).18    
Pearson stated that the iron carbonyl complexes were cheaper to purchase than the corresponding 









CO (55 psi.), 60 h
87%  
Scheme 1.15. An intramolecular Pauson–Khand reaction using an iron transition metal complex. 
 
1.7.6. Rhodium Transition Metal Complex 
Naraska and coworkers purchased a commercially available Rhodium di–nuclear 
complex, [RhCl(CO)2]2, to prepare an intramolecular Pauson–Khand reaction utilizing 1,6–
enynes and carbon monoxide at atmospheric pressure catalytically (Scheme 1.16).19    The 
procedure that was created by Naraska and coworkers can be used on both N,N–allyl propargyl 
sulfonamides and allyl propargyl ethers to make derivatized cyclopentenones.    The 
cyclopentanones made from this procedure were made in moderate to excellent yields. 
2 mol % [RhCl(CO)2]2
Xylene
130 0C









Scheme 1.16. An intramolecular Pauson–Khand reaction using a dirhodium complex. 
 
1.7.7. Iridium Transition Metal Complex 
Shibata and coworkers made a chiral iridium(I) catalyst to produce cyclopentanones with 
high enantioselectivity from either an inter or intramolecular Pauson–Khand reaction.20    It used 
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1,6–enynes and other similar substrates with CO at atmospheric pressure and a chiral iridium–
phosphine complex (Scheme 1.17).    The reaction produced cyclopentenones at moderate–good 
yields with high ee.    The chiral catalyst was prepared in situ from commercially available 
[Ir(COD)Cl]2 and tolBINAP.    The iridium complex employed in the Pauson–Khand reaction of 







10 mol % catalyst
Toluene
reflux
CO (1 atm.), 20 h
80 %, 96 % ee
catalyst = [Ir(COD)Cl]2 + 2(S)-tolBINAP  
Scheme 1.17. Catalytic intramolecular Pauson–Khand reaction using a chiral iridium catalyst 
made in situ. 
 
1.7.8. Tungsten and Chromium Transition Metal Complexes 
Hoye and coworkers compared utilizing group six transition metal Fisher carbene 
complexes with a variety of 1,6–enynes.21    They were able to obtain substituted cyclopropane 
substrates from any of the group six Fisher carbene complexes.    It was discovered that the 
molybdenum carbenes reacted faster than the chromium carbenes which in turn reacted faster 
than the tungsten carbenes in the reactions that were done.    In addition to producing the 
substituted cyclopropane substrates; the tungsten carbenes also produced a bicyclic 
cyclopentenones and it was hypothosized that it was made because the tungsten carbene reacts 
slower and can make a seven–coordinate intermediate and allow the CO insertion to take place 
and also allow the subsequent reductive elimination (Scheme 1.18). 
Moreto demonstrated that an intramolecular Pauson–Khand reaction can be done from 
1,6–enynes and a protodesilyated group six transition metal carbene complexes.22-25    The 
protodesilyated carbene complexes were prepared in situ from fluoride ions to activate the 




















M = Cr: 67 %
    = Mo:81 %
    = W:  48 %
M = Cr: none
    = Mo:none
    = W:  24 %
E = CO2Me  








M = Cr, 4 h, 59 %
















Scheme 1.19. An intramolecular Puson–Khand reaction using Group VI carbenes generated in 
situ from fluoride ions. 
 
1.8. Synthetic Utility 
The Pauson–Khand reaction can be used to synthesize a variety of complex molecules 
found in natural products that contain cyclopentenone moieties and exhibit interesting biological 
and chemical properties.    Here are a few examples of synthesized cyclopentenone natural 
products made from the PK reaction.    Both Moyano and Pericas reported synthesizing (±)–15–
nor–pentalenene from an intramolecular PK reaction (Scheme 1.20).26    The (±)–15–nor–
pentalenene is interesting, because is that it shares the same core structure as (+)–pentalenene.    
(+)–Pentalenene was first synthesized by Paquette and coworkers.27    Because of problems at the 
C–9 juncture, it resulted in the racemization of the final product.    Hua reported the first 
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enantioselective synthesis of (+)–pentalenene.28    It was created from a racemic cis–crotyl 
phenyl sulfoxide and (–)–S–7,7–dimethyl bicycle[3.3.0]–2–octen–3–one and used an 
intramolecular Pauson–Khand reaction.    He never produced (±)–15–nor–pentalenene.    An 
























R = H, (+)-15-Nor-pentalenene






Scheme 1.20. Retro–synthesis of (±)–15 nor–pentalenene using an intramolecular Pauson–
Khand. 
 
Billington reported the synthesis of (±) tetrahydroanhydroaucubigenone from an 
intramolecular Pauson–Khand cycloaddition utilizing substituted allyl–propargyl ethers (Scheme 
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1.21).29    The synthesis of (±) tetrahydroanhydroaucubigenone was done in few steps from 
commercially available reagents.  
Methyl jasmonate was synthesized using the hetero Pauson–Khand reaction.    The 

































R1= H, Jasmonic Acid












The natural product methylenomycin B was made by Billington using an intramolecular 
Pauson–Khand reaction (Scheme 1.23).30    Jernow and coworkers were the first to produced 
methylenomycin B from 2,3–dimethyl cyclopent–2–en–1–one.31    A mistake because the 
structure of methylenomycin A was as incorrectly assigned as methylenomycin B.32    
Methylenomycin A structure contains an oxirane whereas methylenomycin B structure does not 





















Scheme 1.23. Total synthesis of methylenomycin B from an intramolecular Pauson–Khand 
reaction. 
 
Mukai reported the syntheses of (–)–magellanine, (+)–magellaninone, and (+)–
paniculatine from two intramolecular Pauson–Khand reactions which was the main step in 
producing the 6–5–5–6 macrocycle (Scheme 1.24).    (–)–Magellanine was synthesized in 43 
steps and at 1.7% yield, (+)–Magellaninone was made in 43 steps in 1.9% yield and (+)–
paniculatine was produced in 45 steps with an overall yield of 2.8%.33    Overman and coworkers 
were the first to make (–)–magellanine and (+)–magellaninone from the Prins–pinacol 
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rearrangement to produce the 6–5–5–6 core structure.34    Both (–)–magellanine and (+)–
magellaninone and were both created in 25–26 steps from the starting reagent (1R,5S)–
bicycle[3.2.0]heptenone.    Sha was the first to create (+)–paniculatine using an α–carbonyl 
radical–initiated tandem cyclization to make a tricyclic ketone core structure.35    This tricyclic 
structure was converted to (+)–paniculatine in two steps.    An advantage of the Mukai and 
coworkers synthetic strategy is that (–)–magellanine, (+)–magellaninone, and (+)–paniculatine 
can all be made from the same starting reagents using two intramolecular Pauson–Khand 
reactions. 
Danishefsky and coworkers were the first group to synthesize Paecilomycine A.36    
Paecilomycine A was made from a Diels–Alder cycloaddition and an intramolecular Pauson–
Khand reaction (Scheme 1.25).    The enyne employed in the intramolecular Pauson–Khand 
























































Scheme 1.24. Total synthesis of (–)–magelanine, (+)–magellaninone, and (+)–paniculatine from 













































Scheme 1.25. Synthesis of paecilomycine A using an intramolecular Pauson–Khand reaction. 
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α–METHYLENE–γ–BUTYROLACTONE SYNTHESIS AND BACKGROUND VIA THE 
HETERO PAUSON–KHAND REACTION 
 
2.1. Introduction 
An allene is a 1,2–diene  system and the smallest allene unit is called propadiene.    This 
is illustrated in Figure 2.1.    The first allenic acid, glutinic acid, was synthesized in 1887 by 









Figure 2.1. An unsubstituted allene. 
Allenes can be found and isolated from a variety of natural products.    Mycomycin or 3,5,7,8,–
tridecatetracene–10,12–diynoic acid is the second naturally occurring allene C13H10O2.    It was 
isolated from Norcardia acidophilus by Johnson and Burdon in 1947 and it is an antibiotic.   Dr. 
Walter D. Celmer and Dr. I. A. Solmons were later able to isolate mycomycin as a colorless 






Figure 2.2. The second naturally occurring allene compound. 
 
Allenes are interesting compared to an olefin because it has two consecutive double bonds that 
can be used in synthetic reactions.    Allenes can be mono, di, tri or tetra–substituted (Figure 2.3).    
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Today, allenes can be synthesized in a variety of ways and these methods have been summarized 
































Figure 2.3. Mono, di, tri and tetra–substituted allenes. 
 
2.2. The First Allenic Pauson–Khand Reaction 
The allenic Pauson–Khand was first done by Narasaka and coworkers22, 23    They 
discovered that 4–alkylidene cyclopentanones or dienones can be made from photo irradiation, 
Fe(CO)4(NMe3), at ambient temperatures.    The dienone was formed from an η3–allyl 
mononuclear iron complex intermediate and the structure was isolated and identified using x–ray 





















Scheme 2.1. The first allenic intramolecular Pauson–Khand reaction. 
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2.3. Allenic π–Bond Selectivity 
The regular allenic Pauson–Khand reaction demonstrates that an allenic alkyne can be 
reacted via two pathways.    The reaction through pathway 1 uses the internal π–bond of the 
allene to produce an α–methylene cyclopentenone or compound A.    The reaction through 
pathway 2 uses the external π–bond of the allene to create a 4–alkylidene cyclopentenone or 















Pathway 1: R1 = R2 = R3= alkyl 
Pathway 2: R1 = H & R2 = R3 = alkyl
A
B  
Figure 2.4. π–Bond selectivity of allenes. 
2.3.1. Mono–Substituted Allenes  
It was discovered that mono–substituted allenes reacted via the internal π–bond and 












Scheme 2.2. An intramolecular PK reaction of mono–substituted allene. 
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2.3.2. 1,3–Disubstituted Allenes 
         1,3–Disubstituted allenes also produced the same results as the mono–substituted allenes 
when the Pauson–Khand conditions are applied to the starting substrate.    When using transition 
metal complexes such as Co2(CO)8 and Mo(CO)6 with 1,3–disubstituted allenes, α–methylene 
cyclopentenone products are formed as a mixture of E– and Z–isomers.    Because carbonyl 
ligands are not sterically bulky, moderate E–selectivity can be produced when using a limited 
group of substrates with sterically bulky terminal groups on 1,3–disubstituted allenes (Scheme 
2.3).23,25,26    It was discovered that by changing the metal complex and ligands used in the 



























Scheme 2.3. An intramolecular PK reaction of a 1,3–disubstituted allenes. 
When a transition metal complex such as Cp2Zr(n-Bu)2 is used, only the E–isomers were 
obtained.    This is because the cyclopentadienyl ligands, Cp, produced unfavorable steric 
interactions with the R–group on the end of the allene.    This is shown in Figure 2.5.    Pathway 
1 shows the unfavorable steric interaction between the Cp ligands and R1.    Pathway 2 shows the 
favorable steric interaction between the Cp ligands and R1.25 
2.3.3. 3,3–Disubstituted Allenes 
3,3–Disubstituted allenes react via pathway 2 and the external π–bond.    The reason for this 





































60 %  
Scheme 2.4. An intramolecular PK reaction of 3,3–disubstituted allene. 
2.3.4. 1,1,3–Trisubstituted Allenes 
Trisubstituted allenes also react using the least hindered π–bond.25,26,28,29    Shibata and 
coworkers used an iridium complex, CO at 0.2 atm., and an allenyne substrate with two methyl 
groups at the end of the allene functionality to produce an α–methylene cyclopentenone as the 
major product and a triene as a by–product.30    They did not create any diene substrate from this 
reaction.    Next, they replaced the iridium complex with a rhodium transition metal complex and 
subjected it to the same reaction conditions and starting reactants.    This time the first two 
products were prepared as the major compounds and a diene compound was also produced as the 
minor product.    The percent yield of the α–methylene cyclopentenone decreased significantly 
while the percent yield of the triene increased significantly.    Lastly, they used the same iridium 
transition metal complex and reaction conditions and changed only alkynyl allene substrate by 
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having only one methyl group on the terminus of the allene.    The diene compound was the 
major product obtained, and α–methylene cyclopentenones as a mixture of E/ Z isomers.    This 
reaction shows that this methodology is not only based on the reaction conditions, but also on the 















R = Ph, Me, p-MeOC6H4, p-ClC6H4, and Me2PhSi








Scheme 2.5. Syntheses of both α–methylene cyclopentanones and cyclic trienes. 
 
2.3.5. Regio–chemistry and Atmospheric Gas Effects 
Brummond reported the syntheses of three different substrates from a single alkynyl 
allene substrate (Scheme 2.6).    The outcome of the reaction depended on which type of 
transition metal complex used in the reaction and if the reaction was carried out in the presence 
or absence of a CO atmosphere. 31 
2.4. γ–Butyrolactones 
 































Scheme 2.6. Syntheses of three substrates from one synthesized starting material. 
 25
In nature, γ–butyrolactones exist as mono to polycyclic ring systems which can be found 
in more complex molecules.    These compounds exhibit a wide range of biological properties, 
ranging from antibiotic to anti–inflammatory.    These compounds are interesting candidates for 
new drugs.32    Natural products can obtained from γ–butyrolactone intermediates and the 
methods to producing these compounds are summarized in several review articles.32-36    Figure 

















Dilatanolide A  
Figure 2.6. Several γ–butyrolactone examples 
2.4.1. γ–Butyrolactones Syntheses Using Titanium in the Transition Metal Complex 
 
Crowe and coworkers were the first to utilize a titanium complex for a stoichiometric 
intramolecular hetero Pauson–Khand reaction for the synthesis of bicyclic γ–butyrolactones 
(Scheme 2.7).    The phrase hetero Pauson–Khand reaction, HPKR, was coined because the 
carbonyl group replaces one of either alkyne or alkene substrate in the reaction.37 
Buchwald and coworkers reported a titanium complex–mediated or titanium complex as 
a pre–catalyst HPK reaction for the diastereoslective synthesis of bicyclic γ–butyrolactones from 
enones (Scheme 2.8).38    Substituted γ–butyrolactones were also synthesized using catalytic 
amounts of either Cp2Ti(PMe3)2 or Cp2Ti(CO)2 and aryl ketone substrates from enones.    This 
method was limited to aryl ketone substrates (Scheme 2.9).39 
Crowe reported synthesizing γ–butyrolactones from completing an intramolecular HPK 
reaction using enals and enones and a catalytic amount of an asymmetric titanium catalyst.    The 
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30-80 mol % PMe3
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36-40 h, 100 0C
73-92%  
Scheme 2.10. HPK reaction using an asymmetric titanium catalyst. 
2.4.2. Ruthenium Catalyzed Synthesis of γ–Butyrolactones 
Murai and coworkers reported that late transition metals such as ruthenium can facilitate 
the intramolecular HPK reaction (Scheme 2.11).41    They utilized yne–aldehydes substrates, CO, 












10 atm, 160 0C
20 h
82%  
Scheme 2.11. HPK reaction using a catalytic amount of a ruthenium complex. 
 
They also employed the same metal for an intermolecular HPK reaction to produce γ–
butyrolactones (Scheme 2.12).    For this reaction, catalytic amounts of Ru3(CO)12, P(4-
CF3C6H4)3, ethylene, CO and an aldehyde or ketone substrate were used to obtain the γ–
butyrolactones.    Unfortunately, they were not able to explain the effects of the phosphine on the 



















Compounds containing an α–methylene–γ–butyrolactone functionality make-up about 10 
% of the known natural products.43    α–Methylene–γ–butyrolactones exibit a wide range of 
biological activities.    The activities discovered are anti-tumor, cytotoxic, allergic contact 
dermatitis, phytotoxic, antibiotics, insect anti-feedant, vertebrate poisoning, and 
chemoprophylaxis.43-45    α–Methylene–γ–Butyrolactones are synthesized from a variety of 
methods that are summarized in several review articles.33,36,43,44,46    Gadepalli and Rimoldi 
reported that repin bonds covalently with glutathione and other biological molecules with 


































Scheme 2.13. Nucleophilic addition of GSH to Repin. 
2.5.1. α–Methylene–γ–Butyrolactones Synthesis from Ruthenium Catalyzed Hetero–
Pauson–Khand Reaction 
 
Kang and coworkers reported a catalytic intramolecular HPK reaction on various 
substituted allenyl aldehyde and ketone substrates to produce α–methylene–γ–butyrolactones 
(Scheme 2.14).    They also synthesized α–methylene–γ–butyrolactam from a δ–allenyl imine in 
a 53 % yield.48 
2.5.2. Molybdenum Mediated Cyclocarbonylation of α–methylene–γ–butyrolactones 
Yu and coworkers demonstrated that they could accomplish intramolecular HPK 
reactions with substituted allenyl aldehydes and ketones substrates to produce α–methylene–γ–
butyrolactones in moderate to good yields (Scheme 2.15).    They were not able to determine 
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what the role of DMSO was in the reaction or the reaction’s exact mechanistic pathway.    They 














1 mol % Ru3(CO)12
CO (20 atm)
120 0C, 12 h
Dioxane
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6 h, 100 0C
Toluene
75%  
Scheme 2.15. An allenic HPK reaction using a molybdenum catalyst. 
 
2.6. Project Overview 
 
What is known is that from the literature is that substituted α–methylene–γ–
butyrolactones are synthesized by incorporating ruthenium and molybdenum transition metal 
catalyst into HPK reactions.27,48    Can α–methylene–γ–butyrolactones also be created by 
employing titanocene derived transition metal complexes?    The focus of this project was to 
create mono, di, tri and tetra–substituted tethered allene aldehydes and allene ketones that will be 
converted to α–methylene–γ–butyrolactones using titanium mediated intramolecular hetero 
Pauson–Khand reaction.    The general reaction scheme is presented in Figure 2.7. 
2.7. Discussion 
The decision was made to use a tethered mono-substituted allene aldehyde substrate, 
since the goal of the project was to produce an α–methylene–γ–butyrolactone from a titanium 
promoted cyclocarbonylation (Scheme 2.16).    To accomplish this goal, it was decided to first 
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91 %2.1 2.2  
Scheme 2.16. Production of the iodide starting material. 
To further facilitate the goal of the project, it was decided to add the starting material to 
the propargyl chloride substrate and obtain compound 2.3.    Figure 2.8 shows the proposed 
mechanism to produce compound 2.3.50    After purification by column chromatography, a 
mixture of both products 2.2 and 2.3, were obtained and determined by 1H NMR.    The overall 
yield was 50 percent (Scheme 2.17).    Based on the calculations about 30% of the final product 
was the unreacted iodide starting reagent.    To obtain the mono–substituted allene substrate 2.3; 
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we decided to try and trap the iodide starting material, 2.2, by converting it into an ammonium 















5 mol % CuBr SMe2
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Scheme 2.17. Syntheses of both products 2.2 & 2.3. 
The procedure generally worked, but the yields generated were not as good because of separating 
a mixture of products with a moderate to poor percent yield.    We found a better method of 






















Trapped on silica gel.  
Scheme 2.18. Trapping of the substrate 2.2 to produce only substrate 2.3. 
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This particular method initially required the use of a catalytic amount of naphthalene, C10H8.    
The procedure was changed that to a stoichiometric amount because of low yields obtained from 












5 mol % CuBr SMe2





Scheme 2.19. Synthesis of substrate 2.3 from the Reike Zinc method. 
Next, 5 % hydrofluoric acid in acetonitrile was used to cleave the silyl ether protecting 
group from the protected allene.    These reactions were done using glass containers and gave 
low yields.    Since it was known that the fluoride anion somehow reacted with the boro–silicate 

















Scheme 2.20. De–protection of the silyl ether group with HF to produce substrate 2.5 from 2.3. 
 
Milder conditions for the desilylation of the silyl ether group on substrate 2.3 were 

















Scheme 2.21. De–protection of the silyl ether group with TBAF to produce substrate 2.5 from 
2.3. 
 
Oxidizing the primary allenic alcohol to the corresponding aldehyde worked well and 



















Scheme 2.22. Oxidation of the primary alcohol. 
Substrate 2.7 was produced from the titanium metal–complex, Cp2Ti(PMe3)2, insertion 
into substrate 2.5 (Scheme 2.23).56    A crystal structure was also obtained (Figure 2.9).    
Unfortunately, none of the other allenic aldehyde or ketone substrates produced crystals that 



















Scheme 2.23. Metallacycle prepared from a tethered mono–substituted allene. 
A tethered mono–substituted allenic ketone substrate was synthesized to use in a HPK 
reaction (Scheme 2.24).    It was decided to prepare the silyl protected iodo tether first from 2–
methyltetrahydrofuran.    The procedure was similar to the previous allenic aldehyde substrate.57    
It was discovered that 2–methyltetrahydrofuran (2.8) would make two different substrates when 
compound 2.11 was oxidized.    That is because 2–methyltetrahydrofuran was unsymmetrical 
and would produce tert–butyl–(4–iodo–1–methyl–butoxy)–dimethyl–silane and a tert–butyl–(4–
iodo–pentloxy)–dimethyl–silane.    The allenic enal substrate eluted first from the 
chromatography column and was followed by the allenic ketone substrate.    The allenic ketone 
substrate was the major product and the allenic enal compound was the minor product. 
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Scheme 2.24. Production of substrates 2.12 & 2.12a from substrate 2.8. 



















Scheme 2.25. Metallacycle 2.13 produced from HPK reaction of substrate 2.3. 
What kind of allenic substrates would be made from a mono–substituted allene with a 
tether that was shortened by one methylene unit (Scheme 2.26).    If the internal π–bond of hex–
4,5–dienal would react with the titanium complex in the metal insertion; we obtain substrate 
(2.18 b).    It was hypothesized that the major product would the bicyclic substrate, 2.18 a, 
created from the metal insertion with the titanium complex and the external π–bond (Scheme 
2.27).    That is because a five–membered ring in more stable than a four–membered ring.    The 
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Scheme 2.27. The probable metallacycles 2.18a & b that could be prepared from substrate 2.17. 
 
When hex–4,5–dienal reacted with the titanium complex for the metal insertion; only the 











Scheme 2.28. The recovered titanium catalyst from the attempted allenic HPK reaction from 
intermediate 2.17. 
 
Next, disubstituted allenes were synthesized and subjected to cyclocarbonylation.    We 
first focused on making the 1,3–disubstituted allene and it would be followed by the 3,3–
disubstituted allene.    A mixture of products for the 1,3–disubstituted allene was anticipated for 
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the π–bond selectivity of alkynyl allenes.    Propargyl chloride was replaced with 
methanesulfonic acid 1–methyl–prop–2–ynyl–ester.    Methanesulfonic acid 1–methyl–prop–2–
ynyl–ester, 2.20, was created from but–3–yn–2–ol, 2.19, in an 83 % yield.58    Substrate 2.21 was 
made using the “Rieke procedure”, methanesulfonic acid 1–methyl–prop–2–ynyl–ester, 2.20, as 
the electrophile and the iodide starting material 2.2.    The silyl ether protecting group was 
cleaved to produce substrate 2.22 in a 67 % yield and it in turn was oxidized to create substrate 














































Scheme 2.29. Synthesis of substrate 2.23 from 2.19. 
Both compounds 2.24a and 2.24b were obtained as a mixture (4:1 ratio) from starting 



























Scheme 2.30. Metallacycles 2.24a & b produced from substrate 2.23. 
Next, the 3,3–disubstituted allene, 2.28, was synthesized from a Grinard addition to an 
internal alkyne substrate 2.27 (Scheme 2.31).    Butyllithium was employed to abstract a proton 
from methyl propargyl ether, 2.25, to make it undergo a SN2 reaction with the iodide substrate 
2.2 to create substrate 2.27 which could be used to produce a 3,3–disubstituted allene, 2.28.    
Based on proton NMR, it was found that substrate 2.26 was made as the major product and 2.27 



















Scheme 2.31. Production of the undesired major product 2.26. 
Product 2.27 was obtained as the only product when we changed to a new procedure.60    
This procedure used sodium amide, NaNH2 and DMPU instead of butyllithium to de–protonate 
substrate 2.25.    It reacted with 2.2 to produce the desired compound in an 82 % yield (Scheme 
2.32).    It appears that the sodium acetylide reacts mainly at the methylene / iodide bond in 2.2, 
whereas the lithium acetylide reacts preferentially at the oxygen / silicon bond to produce mainly 
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Scheme 2.33. Lithium and Sodium acetylide’s reaction with starting reagent 2.2. 
A 3,3–disubstituted allene 2.28 was created from 2.27 using a copper–catalyzed addition 
of methyl magnesium bromide.61    The silyl ether group on 2.28 was cleaved using the 
deprotection procedure that we optimized to produce substrate 2.29 in an 83 % yield.    Substrate 
2.29 was then oxidized to 2.30 and we predicted that the a 3,3–disubstituted allene would react 
via the internal or more hindered π–bond to produce an α–methylene–γ–lactone (Scheme 2.34 & 
2.35).    Metallacycle 2.31 was obtained as the only product.    Substrate 2.32 was created 
following the same procedure used to obtain compound 2.28 from starting material 2.27 (Scheme 
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2.36).    The tert–butyl–dimethyl silane functional group on 2.32 was removed using TBAF to 




























































Scheme 2.35. Titanacene macrocycle 2.31 prepared from substrate 2.30. 
2.7.1. Substrate Synthesis and Metallacycle Formation 
 
Metallacycle 2.35 was never made when it was reacted with the titanium catalyst.    
Instead, only the catalyst was recovered (Scheme 2.37).    In the end, the desired α–methylene–
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γ–butyrolactones were not produced but the metallocycle synthesis was improved.    It was 








































Scheme 2.37. The failed allenic HPK reaction. 
2.7.2. Carbonylation Studies  
The HPK reaction was attempted using 1 equiv. of compound 2.6, 1equiv. of 
Cp2Ti(PMe3)2, and CO in pentane.    The reaction color changed from red-maroon to yellow in 
color with some precipitate formation (Scheme 2.39).    Judging from the yellow color, the 
desired lactone was not produced.    The experiment was repeated with only the solvent being 
varied.    This time diethyl ether was utilized instead of pentane.    Initially, the reaction color 
was red–maroon for the first two hours; but once again the color changed and the precipitate 
started forming in the reaction flask.    It assumed that there were some sort of unfavorable 
interactions between substrate 2.6, the titanium catalyst, CO and the solvent.    We were able to 
form titanocycle substrates from allenyl aldehyde and ketone substrates in good to excellent 
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yields, with the titanium catalyst and THF as a solvent.    Substrate 2.6 was subjected to the 
cyclocarbonylation at 25 psi. CO and it failed to produce the desired result.    The reaction was 
repeated and only the pressure of CO was varied from 25 to 60 psi. CO.    The desired was not 
obtained lactone. 
The HPK reaction was executed with substrate 2.12 in deuterated benzene at 225 psi. CO.    
No product was obtained after one day of reaction time; but a decrease in CO pressure from 225 
to 202.5 psi. was observed. (Scheme 2.40)     The reaction was heated between 60–75 0C to see if 
it would aid in creating the lactone and ran it for about 2 days using substrate 2.30.    Again, the 
desired product was not obtained.    Compound 2.30 was used in this reaction because it is made 
in higher yields and a shorter synthetic route. 
Compound 2.30 was used in a cyclocarbonylation that was gradually increased from 100 
to ~ 380 psi. CO and ran the reaction for ~ 55 hours.    The product was red–orange dark oil with 
crystals in the round-bottom.    The crystals were taken to the crystallographer, but it apparently 
decomposed because its color faded from red–orange to a dirty brown. (Scheme 2.41) 
2.8. Conclusion 
 
Several metallocycles were the only compounds produced in the attempt to excecute the 
HPK reaction and the substituted α–methylene–γ–butyrolactones were never synthesized. 
2.9. Future Work 
 
The syntheses of α–methylene–γ–butyrolactones could be completed by using a high 
pressure apparatus that can maintain CO pressure as a high as 1500 psi.    A different titanocene 
catalyst can be employed in the HPK reaction to determine if the lactones can be created from 
the corresponding allenyl aldehyde and ketone compounds.    Once the methodology for the 
production of α–methylene–γ–butyrolactones are successful, it could be used to produce lactones 















































































































CO ~ 25 psi.
2.6
Desired Product not Formed
 

























Scheme 2.41. Attempted HPK reaction ran over time using THF and higher CO pressure. 
 
2.10. Experimental Section 
 
All the solvents used in reaction were distilled to dryness according to the following 
procedures.    Tetrahydrofuran (THF) and diethyl ether (Et2O) were both distilled from sodium / 
benzophenone ketyl under nitrogen.    Pentane was distilled from sodium / benzophenone ketyl / 
tetragylme.    Acetonitrile, CH3CN, and methylene chloride, CH2Cl2, were both distilled using 
calcium hydride, CaH2, under nitrogen.    The titanocene complex was made as according to the 
literature procedure.56,62 
Analytical thin–layer chromatography, TLC, was performed on Sorbent Technologies 
silica gel plates with plastic backing.    Components were visualized by illumination with long 
wave ultraviolet light, exposure to iodine vapor, or by standing with one of the following 
reagents (followed by heating): p-anisaldehyde (or vanillin) in ethanol/sulfuric acid; 7% 
phosphomolybdic acid in ethanol; 0.04 M ammonium molybdate in 10% sulfuric acid. Solvents 
for extraction and chromatography were reagent grade and used as received.    Flask column 
chromatography was performed using Sorbent Technologies 60 Å Silica Gel standard grade. 
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2.11. Preparative Procedures 
tert–Butyl–(–4–iodo–butoxy–)–dimethyl–silane (2.2).     tert-Butyldimethylsilyl 
chloride (10.1g, 66.3 mmol, 1 equivalent) was first added to a 500 mL three–necked round–
bottom flask equipped with a stirbar.    Sodium Iodide (19.89g, 132 mmol, 2 equivalents) was 
dissolved in acetonitrile (112 mL) which was introduced by syringed into the three–necked 
round–bottom flask from the left neck.    THF (17.46g, 242 mmol, 3.65 equivalents), 19.64 mL, 
2.1, was also introduced into the three–necked round–bottom flask.    A temperature probe was 
attached to the right neck of the flask to maintain a temperature of 55 0C.    The resulting mixture 
was stirred overnight at 55 0C under nitrogen.    The flask was covered in aluminum foil to 
protect the iodide from exposure to light.    The reaction mixture was quenched with 
approximately 200 mL of water and the combined organic phases from previous extractions were 
concentrated into an orange oily liquid to yield 18.95g (60.3 mmol, 91 % yield).    This protected 
iodo alcohol became substrate 2.2.    The iodide starting material, 2.2, should be stored in a 
refrigerator and wrapped in aluminum foil to avoid light decomposition.    1H NMR (250 MHz, 
CDCl3): δ 3.67 (t, J=6.2 Hz, 2H), 3.23 (t, J=7.0 Hz, 2H), 0.91 (s, 9H), 0.07 (s, 6H);    13C NMR 
(62.8 MHz, CDCl3): δ 62.3, 33.9, 30.6, 26.3, 18.7, 7.6, – 4.9. 
tert–Butyl–hepta–5,6–dienyloxy–dimethyl–silane (2.3).    Activated Zinc dust (325 
mesh, 10.8g, 47.7 mmol, 3 equivalents) was added to a 50 mL RBF with a side arm.    The flask 
was dried by heating under vacuum and it was flushed with nitrogen.    Dry DMF (20 mL) and 
TMSCl (0.146g, 0.975 mmol) were added to the zinc dust and stirred at room temperature for 
approximately 30 minutes.    In separate flask, substrate 2.2 (5g, 15.9 mmol) was added to the 
dry DMF (20 mL) under nitrogen.    Substrate 2.2 was cannulated into the zinc suspension and 
stirred at 0 0C.   Substrate 2.2 was consumed within 5–15 minutes as confirmed by TLC 
(petroleum ether/ EtOAc [2:1]).    The excess zinc dust was allowed to settle for 5 minutes at 0 
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0C and the organozinc supernatant was cannulated into a 100 mL RBF containing a mixture of 
CuBr●S(CH3)2 (0.16g, 5 mol%) and propargyl chloride (1.54g, 20.7 mmol, 1.30 equivalents) in 
DMF (25 mL) at –10 0C.    The resultant mixture was allowed to warm to room temperature and 
stirred for approximately 14 hours.    EtOAc (60 mL) was added to the reaction mixture and it 
was washed with water (3 x 40 mL) and brine (40 mL), then dried over MgSO4 and concentrated 
to produce the crude product mixture of both substrates 2.2 and 2.3 as a yellow oil. 1H NMR (250 
MHz, CDCl3): δ 5.08 (quin, J=6.7 Hz, 1H), 4.62 (m, 2H), 3.59 (t, J=6.3 Hz, 2H), 1.94 (m, 2H), 
1.49 (m, 2H), 1.34 (m, 2H), 0.89 (s, 9H), 0.04 (s, 6H);    13C NMR (62.8 MHz, CDCl3): δ 208.9, 
90.4, 75.1, 63.5, 32.7, 28.5, 26.4, 25.8, 18.8, – 4.8. 
tert–Butyl–hepta–5,6–dienyloxy–dimethyl–silane (2.3).     Zinc chloride (1.19 g, 8.72 
mmol, 1.29 equivalents) and naphthalene (220 mg, 1.72 mmol, 0.267 equivalents) were weighed 
in the glove box and placed into separate 30 mL vials.    Lithium metal (0.12g, 16.9 mmol, 2.67 
equivalents) was weighed and cut into pieces and placed into a 50 mL two–necked round–bottom 
flask which was then evacuated and purged with N2.    Dried THF, 7.60 mL, was then syringed 
into the 30 mL vial with the naphthalene and then it was cannulated into the flask containing 
lithium metal and stirred approximately 15 minutes.    ZnCl2, 1.19 g, was dissolved into about 
8.72 mL of THF.    This solution was then cannulated into a 10 mL addition funnel that was 
attached to 50 mL two–necked round–bottom flask.    The ZnCl2 solution was then added drop–
wise, two drops at a time, with long pauses in between to maintain a green color.    The addition 
was intermittently stopped until the green color returned.    When the addition of ZnCl2 was 
complete; the reaction was stirred for 30 minutes and the green color was gone.    After 30 
minutes of stirring, the stirrer was turned off and the granular grains were allowed to settle.    
The dark grey supernatant was cannulated into a 30 mL vial sealed with a rubber septa and the 
Rieke zinc was pumped on to remove the remaining THF.    The dark grey supernatant was 
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quenched slowly with water and taken to the facilities for disposing of chemicals    DMF (20 
mL) was added to the zinc suspension that was made from the initial reaction.    The reaction 
flask was under ice and at 0 0C, when substrate 2.2 (2 g, 6.36 mmol, 1 equivalent) was added in 7 
mL DMF via cannulation.    The ice was removed and then the mixture was stirred for 1.0 hour 
at room temperature.    In another flask, CuBr●S(CH3)2 (65 mg, 0.318 mmol, 5 mol %) was 
added to DMF (5 mL) and stirred for 30 minutes.    Propargyl chloride (616 mg, 8.27 mmol, 1.3 
equivalents) was syringed into the reaction flask that contained the CuBr●S(CH3)2.    The 
organozinc reaction flask was cooled to –10 0C for 10 minutes and the zinc suspension was 
allowed to settle once again.    The organozinc supernatant was then cannulated into the flask 
that contained the propargyl choloride / CuBr●S(CH3)2.    The reaction flask was allowed to 
warm up from –10 0C to room temperature and stirred for 14 hours.    The reaction mixture was 
quenched in ethyl acetate and the organic layer was concentrated and purified using silica flash 
chromatography (hexanes/ ethyl acetates [90:10]) to produce 914 mg (4.04 mmol, 63 % yield) of 
substrate 2.3 as yellow oil.    1H NMR (250 MHz, CDCl3): δ 5.08 (quin, J=6.7 Hz, 1H), 4.62 (m, 
2H), 3.59 (t, J=6.3 Hz, 2H), 1.94 (m, 2H), 1.49 (m, 2H), 1.34 (m, 2H), 0.89 (s, 9H), 0.04 (s, 6H);    
13C NMR (62.8 MHz, CDCl3): δ 208.9, 90.4, 75.1, 63.5, 32.7, 28.5, 26.4, 25.8, 18.8, – 4.8. 
Hepta–5,6–dien–1–ol (2.5).     Acetonitrile (73 mL) was added to a 500 mL round–
bottom flask that had the substrate 2.3 (1.92g, 8.48 mmol, 1 equivalent) and the resulting 
solution stirred at room temperature.    Approximately 19.30 mL of hydrofluoric acid (48–51 % 
by weight) was syringed into 400 mL beaker that contained 100 mL of CH3CN.    The resulting 
mixture was then added to substrate 2.3 and stirred for about 30 minutes before the first TLC 
were taken to determine if the silyl ether group on 2.3 was cleaved to produce 2.5 as a clear oil.    
The mixture ran for an additional thirty minutes to make certain the reaction ran to completion.    
Substrate 2.5 was purified utilizing silica flash chromatography (hexanes/ EtOAc [8:2], 85 % 
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yield).    1H NMR (250 MHz, CDCl3): δ 5.11 (quin, J=6.7 Hz, 1H), 4.66 (m, 2H), 3.67 (t, J=6.3 
Hz, 2H), 2.04 (m, 2H), 1.65–1.46 (m, 4H);    13C NMR (62.8 MHz, CDCl3): δ 208.9, 90.2, 75.2, 
63.2, 32.6, 28.4, 25.6. 
Hepta–5,6–dien–1–ol (2.5).    Compound 2.3 (2.5g, 11.04 mmol, 1 equivalent) was 
added to a 100 mL round bottom flask equipped with stir bar and 25 mL of THF.    
Approximately 34 mL of TBAF (1.0 M solution in THF) was added to the mixture and it was 
stirred at room temperature for about 1 hour.    At the end of the reaction, the THF was removed 
by roto–evaporation and Et2O was added to the RBF.    The resultant mixture was washed with 
water and dried over MgSO4.    Compound 2.5 was purified using silica–gel flash 
chromatography (hexanes/ EtOAc [8:2]) to produce a clear oil of 0.99 g (8.83 mmol, 80 % 
yield).    1H NMR (250 MHz, CDCl3): δ 5.11 (quin, J=6.7 Hz, 1H), 4.66 (m, 2H), 3.67 (t, J=6.3 
Hz, 2H), 2.04 (m, 2H), 1.65–1.46 (m, 4H);    13C NMR (62.8 MHz, CDCl3): δ 208.9, 90.2, 75.2, 
63.2, 32.6, 28.4, 25.6. 
Hepta–5,6–dienal (2.6).    Pyridinium chlorochromate (5.05g, 23.4 mmol, 2 equivalents) 
was added to 100 mL round–bottom flask and purged. under vacuum.    To this flask, DCM, (20 
mL) added via a syringe.    Neutral alumina (5.05g, 23.4 mmol, 2 equivalents) was also added to 
the flask containing the PCC and it was purged under vacuum a second time and stirred for 30 
minutes at room temperature.    To round–bottom flask containing substrate 2.5 (1.31g, 11.7 
mmol, 1 equivalent) DCM (10 mL) was added.    Substrate 2.5 was cannulated into the round–
bottom flask containingt both the PCC / neutral alumina mixture.    That mixture ran for two–
three hours at room temperature and was checked by TLC to determine if the alcohol was 
consumed completely.    The reaction was quenched with diethyl ether, Et2O, and ran thru a 
silica gel plug.    The mixture was then purified by silica flash chromatography (pentane/ diethyl 
ether [95:05]) and concentrated to make 2.6 in a 70% yield.     1H NMR (250 MHz, CDCl3): δ 
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9.75 (t, J=1.7 Hz, 1H), 5.05 (quin, J=6.7 Hz, 1H), 4.66 (m, 2H), 2.46 (m, 2H), 2.03 (m, 2H), 1.74 
(m, 2H);    13C NMR (75.5 MHz, CDCl3): δ 209.1, 202.8, 89.4, 75.7, 43.6, 27.9, 21.7. 
Substrate (2.7).    This reaction was done in the dry box under argon.    Anhydrous THF 
was added to a 30 mL vial containing substrate 2.6 (125 mg, 1.13 mmol, 1 equivalent).    To this 
vial, Cp2Ti(PMe3)2 (375 mg, 1.13 mmol, 1 equivalent) was added and the reaction mixture was 
stirred for 2 hours.    The reaction mixture was filtered thru a frit–funnel, with a pad of celite, and 
into a small round–bottom flask and pumped on to remove the THF.    The compound was then 
rinsed with pentane to produce a reddish solution and then it was re–crystallized to produce 
substrate 2.7, 307 mg in 94 % yield.    The solvent in the reaction vessel was removed under 
pressure to produce a reddish-brown or maroon colored solid    1H NMR (300 MHz, C6D6): δ 
6.00 (s, 5H), 5.91 (s, 5H), 5.71 (t, 1H), 5.05–5.01 (m, 1H), 4.16 (s, 1H), 3.79–3.71 (m, 1H), 
2.22–2.18 (m, 1H), 1.94–1.84 (m, 2H), 1.53–1.35 (m,  2H);     13C NMR (62.8 MHz, C6D6): δ 
204.2, 116.0, 115.1, 114.8, 85.5, 79.1, 37.5, 36.2, 24.9. 
tert–Butyl–(–4–iodo–1–methyl–butoxy)–dimethyl–silane (2.9).    Substrate 2.9 was 
prepared using a similar procedure described for substrate 2.2.    The product was purified by 
silica flash chromatography (hexane/ EtOAc [98:02]) and concentrated into an orange oily liquid 
to yield 12.67g (58 %).    1H NMR (250 MHz, CDCl3): δ 3.84 (m, 1H), 3.20 (t, J=7.0 Hz, 2H), 
1.89 (m, 2H), 1.52 (m, 2H), 1.13 (d, J=6.0 Hz, 3H), 0.89 (s, 9H), 0.03 (s, 6H);    13C NMR (62.8 
MHz, CDCl3): δ 68.0, 43.6, 30.3, 26.3, 24.2, 18.5, 7.7, – 4.9. 
tert–Butyl–dimethyl–(1–methyl–hepta–5,6–dienyloxy)–silane (2.10).    Substrate 2.10 
was prepared from procedures for substrate 2.3.    The product was purified using silica gel flash 
chromatography (hexane/ EtOAc [9:1]) to yield 3.13 g (85 %) as a clear oil.    1H NMR (300 
MHz, CDCl3): δ 5.10 (quin, J=6.7 Hz, 1H), 4.86 (m, 2H), 3.81 (q, J=5.5 Hz, 1H), 2.00 (m, 2H), 
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1.48 (m, 2H), 1.43 (m, 2H), 1.13 (d, J=6.1 Hz, 3H), 0.90 (s, 9H), 0.06 (s, 6H);    13C NMR (75.5 
MHz, CDCl3): δ 208.9, 90.4, 75.1, 68.9, 39.5, 28.7, 26.3, 25.8, 24.3, 18.7, – 4.3. 
Octa–6,7–dien–1–ol (2.11).    Substrate 2.11 was prepared from substrate 2.10 (2.77 g, 
11.52 mmol, 1 equivalent) using the procedure described for substrate 2.5.    The product was 
purified by silica flash chromatography (hexane/ EtOAc [8:2]) to yield 76 % as a transparent oil.    
1H NMR (300 MHz, CDCl3): δ 5.16 (quin, J=6.7 Hz, 1H), 4.74 (m, 2H), 3.84 (q, J=5.6 Hz, 1H), 
2.09 (m, 2H), 1.51 (m, 2H), 1.49 (m, 1H), 1.40 (s, 1H), 1.24 (d, J=6.2 Hz, 3H);    13C NMR (62.8 
MHz, CDCl3): δ 208.9, 96.2, 75.2, 68.3, 39.1, 28.5, 25.6, 23.9. 
Octa–6,7–dien–2–one (2.12).    Substrate 2.12 was prepared from substrate 2.11 (1.10 g, 
8.79 mmol, 1 equivalent) using the procedure described for substrate 2.6.    The product was 
purified by silica flash chromatography (pentane/ diethyl ether [95:05]) to yield 962mg (88.26 
%) as a clear oil.    Compound 2.12 eluted first from the column.    1H NMR (300 MHz, CDCl3): 
δ 5.07 (quin, J=6.7 Hz, 1H), 4.68 (m, 2H), 2.48 (m, 2H), 2.15 (s, 3H), 2.00 (m, 2H), 1.74 (m, 
2H);    13C NMR (62.8 MHz, CDCl3): δ 209.1, 206.3, 89.9, 75.2, 42.6, 29.5, 28.0, 23.5.    4–
Methyl–hepta–5,6–dienal (2.12a).    Substrate 2.12a was the minor product isolated in a trace 
amount from the oxidation of compound 2.11a.    1H NMR (300 MHz, CDCl3): δ 9.79 (t, J=5.8 
Hz, 1H), 5.03 (quin, J=6.7 Hz, 1H), 4.74 (m, 2H), 2.52 (m, 3H), 2.21 (m, 2H), 1.07 (d, J=6.8 Hz, 
3H). 
Metallacycle 2.13 was prepared from substrate 2.12 (200 mg, 1.61 mmol, 1 equivalent) 
using the improved procedure described for substrate 2.7.    The product was collected as a 
reddish oil to yield 435 mg (89 %).    1H NMR (300 MHz, C6D6): δ 5.98 (s, 5H), 5.95 (s, 5H), 
5.74 (s, 1H), 4.22 (s, 1H), 3.93 (m, 1H), 2.18 (m, 2H), 1.77 (m, 2H), 1.33 (m, 2H), 1.23 (s, 3H);    
13C NMR (62.8 MHz, C6D6): δ 203.9, 115.5, 115.2, 114.9, 94.2, 82.0, 42.8, 35.3, 30.4, 24.7. 
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tert–Butyl–hexa–4,5–dienyloxy–dimethyl–silane (2.15).    Substrate 2.15 was prepared 
using the procedure for substrate 2.3.    The product was purified using silica flash 
chromatography (hexane/ EtOAc [98:02]) to yield 1.64 g (39 %).    1H NMR (300 MHz, CDCl3): 
δ 5.15 (quin, J=6.7 Hz, 1H), 4.69 (m, 2H), 3.64 (t, J=4.0 Hz, 2H), 2.09 (m, 2H), 1.69 (m, 2H), 
0.90 (s, 9H), 0.07 (s, 6H);    13C NMR (62.8 MHz, CDCl3): δ 208.9, 90.1, 75.3, 62.8, 32.4, 26.4, 
24.8, 18.7. 
Hexa–4,5–dien–1–ol (2.16).    Substrate 2.16 was prepared from substrate 2.15 (1.64 g, 
7.72 mmol, 1 equivalent) using the procedure described for substrate 2.5 a.    The product was 
purified by silica flash chromatography (hexane/ EtOAc [8:2]) to yield 428mg (56 %) as a clear 
oil.    1H NMR (300 MHz, CDCl3): δ 5.11 (quin, J=6.7 Hz, 1H), 4.65 (m, 2H), 3.65 (t, J=6.0 Hz, 
2H), 2.03 (m, 2H), 1.99 (m, 1H), 1.67 (m, 2H);    13C NMR (62.8 MHz, CDCl3): δ 208.9, 89.8, 
75.5, 62.7, 32.3, 24.8. 
Hexa–4,5–dienal (2.17).    Substrate 2.17 was prepared from substrate 2.16 (428 mg, 
4.36 mmol, 1 equivalent) using the procedure described for substrate 2.6.    The product was 
purified by silica flash chromatography (pentane/ diethyl ether [95:05]) to yield 74.4 mg (18 %) 
as a clear oil.    1H NMR (300 MHz, CDCl3): δ 9.81 (s, 1H), 5.20 (m, 1H), 4.76 (m, 2H), 2.59 (m, 
2H), 2.33 (m, 2H);    13C NMR (75.5 MHz, CDCl3): δ 210.0, 203.5, 90.2, 78.0, 43.9, 22.1. 
Methanesulfonic acid 1–methyl–prop–2–ynyl–ester (2.20).    To a 500 mL round–
bottom flask equipped with a stir bar; NEt3, (18.04 g, 178.3 mmol, 2.5 equivalents) [24.85 mL] 
was syringed into a solution of but–3–yn–2–ol, 2.19, (5 g, 71.33 mmol, 1 equivalent) in DCM 
(120 mL).    Me3N●HCl (6.82 g, 71.33 mmol, 1 equivalent) was also added to the reaction 
mixture.    The round–bottom flask was cooled to 0 0C before the syringing in the mesyl 
choloride (12.26 g, 107 mmol, 1.5 equivalents) in DCM (20 mL).    The mixture was then stirred 
for about 1 hour and quenched with water.    It was then extracted with ethyl acetate and the 
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organic phase was washed with brine and water.    The combined organic phase was dried with 
Na2SO4, and concentrated and purified by silica flash chromatography (hexane/ EtOAc [95:05]) 
to produce 8.76 g (83 %) of substrate 2.20 as yellow oil.    1H NMR (300 MHz, CDCl3): δ 5.28 
(qd, J=6.7 Hz, J=2.1 Hz, 1H), 3.12 (s, 3H), 2.70 (d, J=2.0 Hz, 1H), 1.65 (d, J=6.7 Hz, 3H);    13C 
NMR (62.8 MHz, CDCl3): δ 80.6, 76.6, 67.9, 39.5, 21.4. 
tert–Butyl–dimethyl–octa–5,6–dienloxy–silane (2.21).    Substrate 2.21 was prepared 
using the procedure for substrate 2.3.    The product was purified using silica flash 
chromatography (hexane/ EtOAc [98:02]) to yield 1.39 g (36 %) as clear oil.    1H NMR (300 
MHz, CDCl3): δ 5.06 (m, 2H), 3.65 (t, J=6.3 Hz, 2H), 2.20 (m, 2H), 1.68 (m, 3H), 1.62–1.44 (m, 
4H), 0.97 (s, 9H), 0.10 (s, 6H);    13C NMR (75.5 MHz, CDCl3): δ 206.3, 91.8, 87.1, 64.7, 33.8, 
30.2, 27.5, 27, 19.9, 16.1, – 3.7. 
Octa–5,6–dien–1–ol (2.22).    Substrate 2.22 was prepared from substrate 2.21 (1. 2 g, 
4.49 mmol, 1 equivalent) using the procedure described for substrate 2.5a.    The product was 
purified by silica flash chromatography (hexane/ EtOAc [8:2]) to yield 421 mg (67 %).    1H 
NMR (300 MHz, CDCl3): δ 5.03 (m, 2H), 3.63 (m, 2H), 1.99 (m, 2H), 1.62 (m, 3H), 1.60–1.48 
(m, 4H);    13C NMR (75.5 MHz, CDCl3): δ 206.3, 91.6, 87.2, 64.3, 33.7, 30.1, 26.8, 16.1. 
Octa–5,6–dienal (2.23).    Substrate 2.23 was prepared from substrate 2.22 (421 mg, 3.34 
mmol, 2 equivalents) using the procedure described for substrate 2.6.    The product was purified 
by silica flash chromatography (pentane/ diethyl ether [95:05]) to yield 373mg (90 %) of a clear 
oil.    1H NMR (300 MHz, CDCl3): δ 9.74 (s, 1H), 5.02 (m, 2H), 2.45 (m, 2H), 2.02 (m, 2H), 
1.73 (m, 2H), 1.65 (dd, J=3.3 Hz, 3H);    13C NMR (62.8 MHz, CDCl3): δ 206.2, 205.3, 90.1, 
86.1, 43.5, 28.4, 22.4, 14.8. 
Metallacycles 2.24a and b were both prepared as mixture (ratio 4:1) from substrate 2.23 
(200 mg, 1.61 mmol, 1 equivalent) using the procedure described for substrate 2.7.    The product 
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was collected as a reddish oil to yield 391 mg (80 %).    Substrate 2.24a:    1H NMR (300 MHz, 
C6D6): δ 6.11 (s, 5H), 6.02 (s, 5H), 5.22 (m, 1H), 4.29 (m, 1H), 3.90 (m, 1H), 2.18–1.35 (m, 6H), 
1.74 (d, J=6.4 Hz, 3H); 13C NMR (75.5 MHz, C6D6): δ 191.5, 124.9, 116.2, 115.4, 86.3, 76.1, 
38.5, 34.9, 26.2, 17.8.    Substrate 2.24b:    1H NMR (300 MHz, C6D6): δ 6.18 (s, 5H), 6.08 (s, 
5H), 5.96 (m, 1H), 5.15 (m, 1H), 3.70 (m, 1H), 1.66–1.35 (m, 6H), 1.22 (d, J=6.4 Hz, 3H);    13C 
NMR (75.5 MHz, C6D6): δ 192.4, 124.0, 115.5, 114.5, 85.7, 80.9, 38.7, 37.7, 25.8, 20.7. 
tert–Butyl–(7–methoxy–hepta–5–ynyloxy)–dimethyl–silane (2.27).    Butyllithium 
(33.7 mL of 2.0 M solution in hexanes, 69.4 mmol) was added to substrate 2.25 (5 g, 71.3 mmol) 
over a 40 minutes in 500 mL of dried THF at 0 0C.    Substrate 2.2 (11.2 g, 35.6 mmol) was 
added via a syringe.    The reaction was refluxed for four days and cooled to room temperature 
and quenched with approximately 100 mL of water.    The THF was removed via reduced 
pressure and the residue was extracted using diethyl ether (5x50 mL).    The combined organic 
phase was dried over MgSO4 and purified using flash column chromatography (hexanes/ EtOAc 
[9:1]) to yield 15 % (1.34 g) as a yellow oil.    1H NMR (300 MHz, CDCl3): δ 4.07 (t, J=2.1 Hz, 
2H), 3.62 (t, J=5.9 Hz, 2H), 3.36 (s, 3H), 2.26 (m, 2H), 1.60 (m, 4H), 0.89 (s, 9H), 0.04 (s, 6H).    
13C NMR (62.8 MHz, CDCl3): δ 87.4, 76.3, 63.0, 60.6, 57.8, 32.3, 26.3, 25.5, 19.0, 18.7, – 4.9. 
tert–Butyl–(7–methoxy–hepta–5–ynyloxy)–dimethyl–silane (2.27).     To 250 mL 
round–bottom flask equipped with a stir bar and in the dry box; sodium amide (1.65 g, 42.3 
mmol, 1.29 equivalents) was added and then 45 mL of dry THF was syringed into the flask.    
The flask was cooled to –78 0C and methyl propargyl ether, 2.25, (2.3 g, 32.8 mmol, 1 
equivalent), 2.77 ml in 5 mL of THF, was syringed into the flask.    The reaction mixture was 
then cooled to –78 0C for 1 hour and then warmed to room temperature for 1 hour to make 
certain that the acetylide had formed.    The mixture was once again cooled to – 78 0C and 
DMPU, (7.99 g, 62.3 mmol, 1.9 equivalents), 7.54 mL, was syringed into the flask.    Substrate 
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2.2 (12.27 g, 39 mmol, 1.19 equivalents) in 5 mL of THF was syringed into the flask containing 
the DMPU, 2.25 and NaNH2.  The reaction mixture was ran for 16 hours and quenched with 15 
mL of saturated ammonium chloride.    The quenched solution was poured into a separatory 
funnel with about 100 mL of both water and ether in it.    The organic phases were washed two 
more times with water and then dried with MgSO4.    It was concentrated and purified by silica 
flash chromatography (hexane/ EtOAc [9:1]) to produce substrate, 2.27, in 82 % yield (6.91 g) as 
a clear oil.     Substrate 2.27 was separated into three aliquots.    Substrate 2.28 was made from 3 
g of 2.27, 2.32 was made from 3.62 g of 2.27 and the remainder was used for a NMR and IR 
samples.    1H NMR (300 MHz, CDCl3): δ 4.07 (t, J=2.1 Hz, 2H), 3.62 (t, J=5.9 Hz, 2H), 3.36 (s, 
3H), 2.26 (m, 2H), 1.60 (m, 4H), 0.89 (s, 9H), 0.04 (s, 6H).    13C NMR (62.8 MHz, CDCl3): δ 
87.4, 76.3, 63.0, 60.6, 57.8, 32.3, 26.3, 25.5, 19.0, 18.7, – 4.9. 
tert–Butyl–dimethyl–(5–methyl–hepta–5,6–dienyloxy)–silane (2.28).    Copper (I) 
bromide (503.4 mg, 3.51 mmol, 0.30 equivalents) was added to a 250 mL round–bottom flask 
equipped with a stir bar.    To this flask, substrate, 2.27, (3 g, 11.7 mmol, 1 equivalent) was 
added in 100 mL of Et2O.    Methylmagnesium bromide (2.79 g, 23.39 mmol, 2 equivalents), 
[7.80 mL] was syringed drop–wise into the mixture of substrate 2.27 and CuBr.    The reaction 
mixture was stirred at room temperature and then refluxed for 60 hours.    After running for 60 
hours; the mixture was quenched carefully and drop–wise under ice because it was an 
exothermic reaction.    The organic layers were extracted using ether and washed in brine and 
dried with Na2SO4 and concentrated and purified using silica flash chromatography (hexane/ 
EtOAc [9:1]) to produce substrate 2.28, 1.15 g (43 %) as a clear oil.    1H NMR (300 MHz, 
CDCl3): δ 4.60 (m, 2H), 3.66 (m, 2H), 1.95 (m, 2H), 1.68 (m, 3H), 1.54 (m, 2H), 1.49 (m, 2H), 
0.90 (s, 9H), 0.06 (s, 6H);    13C NMR (62.8 MHz, CDCl3): δ 206.6, 98.7, 74.3, 63.5, 33.6, 32.8, 
26.4, 24.1, 19.0, 18.8, – 4.9. 
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5–Methyl–hepta–5,6–dien–1–ol (2.29).    Substrate 2.29 was prepared from substrate 
2.28 (1. 15 g, 4.78 mmol, 1 equivalent) using the procedure described for substrate 2.5.    The 
product was purified by silica flash chromatography (hexanes/ EtOAc [8:2]) to yield 500 mg (83 
%) as a clear oil.    1H NMR (300 MHz, CDCl3): δ 4.59 (m, 2H), 3.65 (t, J=6.2 Hz, 2H), 1.97 (m, 
2H), 1.67 (m, 3H), 1.61–1.50 (m, 4H), 0.05 (s. 6H).    13C NMR (62.8 MHz, CDCl3): δ 206.5, 
98.6, 74.5, 63.3, 33.5, 32.7, 23.9, 19.1. 
5–Methyl–hepta–5,6–dienal (2.30).    Substrate 2.30 was prepared from substrate 2.29 
(500 mg, 3.96 mmol, 1 equivalent) using the procedure described for substrate 2.6.    The product 
was purified by silica flash chromatography (pentane/ EtOAc [95:05]) to yield 148 mg (30 %).    
1H NMR (300 MHz, CDCl3): δ 9.71 (t, 1H), 4.65–4.45 (m, 2H), 2.42 (m, 2H), 1.97 (m, 2H), 1.79 
(m, 2H), 1.67 (m, 3H).    13C NMR (62.8 MHz, CDCl3): δ 206.5, 202.9, 97.9, 75.0, 43.7, 32.0, 
20.2, 19.1. 
Metallacycle 2.31 was prepared as mixture from substrate 2.30 (148 mg, 1.192 mmol, 1 
equivalent) using the procedure described for substrate 2.7.    The product was collected as a 
reddish oil to yield 307 mg (85 %).    1H NMR (250 MHz, C6D6): δ 6.09 (s, 5H), 5.98 (s, 5H), 
5.84 (s, 1H), 4.82 (m, 1H), 4.09 (s, 1H), 1.71–1.47 (m, 6H), 1.26 (s, 3H);    13C NMR (62.8 MHz, 
C6D6): δ 207.8, 114.9, 114.1, 113.7, 92.0, 82.5, 42.3, 35.0, 26.6, 23.7. 
tert–Butyl–dimethyl–(5–phenyl–hepta–5,6–dienyloxy)–silane (2.32).    Substrate 2.32 
was prepared from substrate 2.27 (3.62 g, 14.1 mmol, 1 equivalent) using the procedure for 
substrate 2.28.    The product was purified by silica flash chromatography (hexane/ EtOAc [9:1]) 
to yield 3.44 g (81 %).    1H NMR (300 MHz, CDCl3): δ 7.47–7.23 (m, 5H), 5.11 (m, 2H), 3.66 
(m, 2H), 2.49 (m, 2H), 1.67–1.60 (m, 4H), 0.96 (s, 9H), 0.10 (s, 6H);    13C NMR (75.5 MHz, 
CDCl3): δ 210.2, 138.0, 129.9, 128.1, 127.6, 106.5, 79.8, 64.6, 34.1, 30.8, 27.6, 25.8, 20.0, – 3.7. 
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5–Phenyl–hepta–5,6–dien–1–ol (2.33).    Substrate 2.33 was prepared from substrate 
2.32 (3.44 g, 11.37 mmol, 1 equivalent) using the procedure described for substrate 2.5a.    The 
product was purified by silica flash chromatography (hexane/ EtOAc [8:2]) to yield 1.54 g (72 
%) as a clear oil.    1H NMR (300 MHz, CDCl3): δ 7.42–7.22 (m, 5H), 5.12 (m, 2H), 3.72 (m, 
2H), 2.15 (m, 2H), 1.74–1.65 (m, 4H);    13C NMR (62.8 MHz, CDCl3): δ 209.0, 130.4, 128.6, 
127.8, 126.8, 105.2, 78.8, 63.1, 32.8, 29.6, 25.3. 
5–Phenyl–hepta–5,6–dienal (2.34).    Substrate 2.34 was prepared from substrate 2.33 
(1.54 g, 8.18 mmol, 1 equivalent) using the procedure described for substrate 2.6.    The product 
was purified by silica flash chromatography (pentane/ EtOAc [95:05]) to yield 529 mg (35 %) as 
a clear oil.    1H NMR (300 MHz, CDCl3): δ 9.79 (s, 1H), 7.42–7.34 (m, 5H), 5.12 (m, 2H), 
2.56–2.49 (m, 4H), 1.94 (m, 2H);    13C NMR (75.5 MHz, CDCl3): δ 210.1, 204.0, 137.5, 130.0, 
128.4, 127.5, 105.7, 80.3, 45.0, 30.3, 21.8. 
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Methyl Jasmonate and Jasmone were both isolated from Jasminium Grandiflorum L. by 











Figure 3.1. Images of both Methyl jasmonate & Jasmone. 
Four stereoisomers of methyl jasmonate exist.    Arcee has shown that 1R, 2S (+)-Z-
Methyl Epijasmonate has been known to posses the strongest odor.2    1R, 2R (–)–Z–Methyl 
Jasmonate has a weak odor.    They also discovered that both the remaining isomers are odorless.    
The images of the four stereoisomers are shown in figure 3.2. 
3.2. The Utility of Methyl Jasmonate 
Bonfill and coworkers utilized methyl jasmonate to produce both Paciltaxel and Baccatin 
III in cell culture.3    The Taxus baccata L. cell suspensions were kept in 175–cm3 flasks that 
were capped with magenta B–caps.    This suspension was kept at room temperature, stirred at 
100 rpm in a shaker–incubator and in the dark.    Gamborg’s B5 medium used to grow both 
Paciltaxel and Baccatin III.    One advantage of Bonfill’s group method is that Paciltaxel can be 




















A = 1R,2S (+)-Z-Methyl Epijasmonate 
B = 1R,2R (-)-Z-Methyl Jasmonate
C = 1S,2S (+)-Z-Methyl Jasmonate
D = 1S,2R (-)-Z-Methyl Epijasmonate  
Figure 3.2. Four isomers of Methyl Jasmonate. 
The extraction method utilized a large amount of the bark to produce a few grams of the product.    
What they discovered was that the overall concentration of methyl jasmonate for the Paciltaxel 
synthesis didn’t really matter as long as the production of Paciltaxel was increased.    What 
makes Paciltaxel interesting is that it is an anti–cancer drug that was first isolated from the 


















Figure 3.3. An image of Paciltaxel. 
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Jasmonates are involved in wound response of plants because of external damage caused by 
grazing animals, insects and microbes.5 
 
3.3. The Biosynthesis of Jasmonic Acid & Methyl Jasmonate 
Methyl Jasmonate & Jasmonic Acid can be synthesized in plants.    The biosynthesis of 
Jasmonic Acid starts with α–linolenic acid which is converted to 10,11–dihydro–12–
oxophytodienoic acid through several steps.    Jasmonic Acid is produced from three β–
oxidations from 10,11–dihydro–12–oxophytodienoic acid.    Jasmonic Acid is converted to 
Methyl Jasmonate by ester formation and epimerization of the C–7 bond.5,6    Figure 3.4 shows 











3 X Beta - Oxidations
Alpha-Linolenic Acid
 
Figure 3.4. Biosynthesis of Jasmonic Acid & Methyl Jasmonate. 
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3.4. The Chemical Syntheses of Methyl Jasmonate  
Methyl Jasmonate is mainly utilized in the perfume industry because it has a jasmine 
fragrance.    It was later discovered that Methyl Epijasmonate possessed the key jasmine 
component or fragrance.7    Because of its importance to perfume industry, many synthetic 
groups have tried and been successful at producing methyl jasmonate in the lab.    Masahisa 
Nakada’s paper presents several dozen references for the synthesis of methyl jasmonate.8 
 
3.4.1. Sisido’s Group  
Methyl Jasmonate was synthesized from the pyrrolidine enamine of methyl 2–
oxocyclopentane–1–acetate in an overall 31 % yield.9    Substrate 7 was synthesized utilizing an 
intramolecular aldol condensation of compound 3 and a double bond migration to the more 
substituted olefin.    It was made in a 56 % yield.    The olefin in compound 7 was exposed to 
H2O2 in a basic solution to produce substrate 9 which contained an oxirane functionality.    
Compound 9 was made in a 61 % yield.    Compound 9 was converted to substrate 10 in a 51 % 
yield using an Eschenmoser fragmentation.    Methyl Jasmonate was made from compound 10 
using a Lindlar Catalyst in 60 % yield.    Scheme 3.1 shows the Sisido groups’ reaction scheme. 
 
3.4.2. G. Buchi’s Group 
Methyl Jasmonate was synthesized from 1,3–cyclohexadione by Buchi.10    1,3–
Cyclohexandione was transformed into compound 3 in an 83 % yield using 1-bromo-2-pentyne 
in aqueous KOH.    Substrate 4 was produced in a 76 % yield when compound 3 was chlorinated 
with tert–butyl hypochlorite.    Substrate 5 was not isolated because when cyclopropanones are 
exposed to high temperatures from refluxing in xylene; they go thru a decarbonylation to 
produce an olefin such as compound 6 and carbon monoxide.    Compound 6 was made in 74 % 
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yield when substrate 4 was added to sodium carbonate.    They utilized sodium carbonate in this 
transformation because they needed a base not susceptible to accepting the positive chlorine 
atom from compound 4.    When the reaction is carried out in the absence of sodium carbonate; 
compound 3 was the main product obtained instead of the substrate 6.    Compound 7 was made 
in a 96 % yield.    The hydrolysis of compound 7 and its subsequent decarboxylation lead to the 
production of compound 8 in an 80 % yield.    Substrate 8 was esterifies to compound 9 in a 94 
% yield and the acetylene functionality of substrate 9 was reduced utilizing Lindlar’s catalyst to 
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Scheme 3.1. Sisido’s synthesis of racemic Methyl Jasmonate. 
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3.4.3. Negishi’s Group 
Negishi synthesized Methyl Jasmonate from a cyclopentenone precursor.11    A 1,4–
cuprate addition to the cyclopentenone starting material produced substrate 6 in an 86 % yield.    
Substrate 11 was made from compound 6 using a palladium catalyzed cross coupling reaction.    
Compound 12 was made as a crude product when the external vinyl group on 11 was subjected 
to hydroboration–oxidation conditions to produce a primary alcohol.    This primary alcohol was 
oxidized in the presence of Na2Cr2O7 and H2SO4 to make the 12 with the carboxylate 
functionality.    Methyl Jasmonate, 10, was made in an overall 70 % yield from the 


























































































Scheme 3.3. Negishi’s synthesis of Methyl Jasmonate. 
3.5. Discussion 
5–Bromo–penta–1,3–diene was prepared from the protonation of the alcohol substituent 
on penta–1,4–dien–3–ol with HBr and its subsequent rearrangement to form a diene allylic 
carbocation that added a bromide anion.    It was made in 74 % yield as a dark yellow oil.    




0 0C, 3 h
74 %  
Scheme 3.4. Production of the divinyl compound 3.2. 
3–(tert–Butyl–dimethyl–silanyloxy)–propionaldehyde was prepared from the oxidation 
of 3–(tert–Butyl–dimethyl–silanyloxy)–propan–1–ol using PCC and Al2O3.    It was produced as 











Scheme 3.5. The oxidation of the primary alcohol to aldehyde 3.4. 
1–(tert–Butyl–dimethyl–silanyloxy)–4–vinyl–hex–5–en–3–ol, 3.5, was prepared by 
pentadienylation.12    This reaction used 5–Bromo–penta–1,3–diene, 3.2, 3–(tert–Butyl–
dimethyl–silanyloxy)–propionaldehyde, 3.4, and indium to create a clear yellow oil in ~ 86 % 












0 0 - rt., 3 h
86 %  
Scheme 3.6. The production of substrate 3.5 from substrates 3.2 & 3.4. 
The hydroxyl group which is a poor leaving group on 1–(tert–Butyl–dimethyl–
silanyloxy)–4–vinyl–hex–5–en–3–ol, 3.5, was converted into a mesylate group.13    Mesylate 
groups are good leaving groups and intermediate 3.5 was converted into methanesulfonic acid 1–
[2–(tert–Butyl–dimethyl–silanyloxy)–ethyl]–2–vinyl–but–3–enyl ester, 3.6, as a red-orange oil 










88 %  
Scheme 3.7. The production of the mesylated compound 3.6. 
The mesylate functionality on methanesulfonic acid 1–[2–(tert–Butyl–dimethyl–
silanyloxy)–ethyl]–2–vinyl–but–3–enyl ester, 3.6, was displaced using an SN2 mechanism and a 
hydride from LAH to produce 4–vinyl–hex–5–en–1–ol, 3.7a.    Compound 3.7a was the desired 
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and also un–intended product.     That is because this compound eliminated the need for an extra 
reaction.    tert–Butyl–dimethyl–(4–vinyl–hex–5–enyloxy)–silane, 3.7b, was also produced and 
purified from the same reaction.    Both compounds made clear yellow oils in 72 % for the 









0 0 - rt.
overnight 72 % 19 %  
Scheme 3.8. Products 3.7a & b produced from compound 3.6. 
The silyl ether protecting of tert–butyl–dimethyl–(4–vinyl–hex–5–enyloxy)–silane, 3.7b, 








Scheme 3.9. Conversion from substrate 3.7b to 3.7a. 
4–vinyl–hex–5–en–1–ol, 3.7 a, was oxidized to 4–vinyl–hex–5–enal, 3.8, using PCC and 








33 %  
Scheme 3.10. Oxidation of the primary alcohol to the aldehyde 3.8. 
4–vinyl–hexahydro–cyclopenta[b]furan–2–one, 3.9, was made from utilizing 1 equivalent 
of 4–vinyl–hex–5–enal, 1 equivalent of Cp2Ti(PMe3)2 and ~ 40 psi CO in the hetero Pauson-
Khand reaction to make a dark yellow-orange oil in ~ 48 % yield.    Scheme 3.11 shows the 











Scheme 3.11. Conversion of substrate 3.8 to 3.9. 
2–Pent–2–enyl–3–vinyl–cyclopentanol, 3.10, was made from compound 3.9.15    This 
reaction involved reducing the intermediate 3.9 by DIBAL-H reduction to the lactol which was 
followed by the subsequent Wittig reaction with Ph3P=CHCH2CH3.    Substrate 3.10 was created 












Scheme 3.12. The production of compound 3.10 from the lactone intermediate 3.9. 
3–(2–Hydroxy–ethyl)–2–pent–2–enyl–cyclopentanol was made by doing a 
hydroboration–oxidation with 9-BBN on the unsubstituted vinyl group on substrate 3.11.16     











88 %  
Scheme 3.13. Hydroboration–oxidation of compound 3.10 to diol 3.11. 
(3–Oxo–2–pent–2–enyl–cyclopentyl)–acetic acid or jasmonic acid, 3.12, was made from 
the Jones Oxidation of 3–(2–Hydroxy–ethyl)–2–pent–2–enyl–cyclopentanol, 3.11.17    A pale 
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yellow oil was obtain at ~ 10 mg.    Scheme 3.14 shows the Jones oxidation of both the primary 













Scheme 3.14. Jones Oxidation of both the primary & secondary alcohols on diol intermediate 
3.11 to 3.12. 
 
Methyl Jasmonate, 3.13 was made from using the crude form of substrate 3.12.18    Substrate 













Scheme 3.15. Production of the target molecule Methyl jasmonate 3.13. 
 
3.6. Conclusion 
Methyl jasmonate was synthesized as a pale yellow oil at 14 mg from jasmonic acid. 
3.7. Experimental Section 
All the solvents used in reaction were distilled to dryness according to the following 
procedures.     Tetrahydrofuran (THF) and diethyl ether (Et2O) were both distilled from sodium / 
benzophenone ketyl under nitrogen.   Pentane was distilled from sodium / benzophenone ketyl / 
tetraglyme.    Acetonitrile, CH3CN, and methylene chloride, CH2Cl2, were both distilled using 
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calcium hydride, CaH2, under nitrogen.    The titanocene complex was made as according to the 
literature procedure.19,20 
Analytical thin–layer chromatography (TLC) was performed on Sorbent Technologies 
silica gel plates with plastic backing.    Components were visualized by illumination with long 
wave ultraviolet light, exposure to iodine vapor, or by standing with one of the following 
reagents (followed by heating): p–anisaldehyde (or vanillin) in ethanol/sulfuric acid; 7% 
phosphomolybdic acid in ethanol; 0.04 M ammonium molybdate in 10% sulfuric acid. Solvents 
for extraction and chromatography were reagent grade and used as received.    Flask column 
chromatography was performed using Sorbent Technologies 60 Å Silica Gel standard grade. 
3.8. Preparative Procedures 
5–Bromo–penta–1,3–diene (3.2).    To a 250 mL round bottom flask containing penta–
1,4–dien–3–ol, 3.1, (14.82g, 176.18 mmol, 1 equiv.) that was purged by vacuum and flushed 
with nitrogen.    HBr (21.38g, 264.27 mmol, 1.5 equiv.) was added dropwise at 0 0C.    The 
reaction mixture was stirred at 0 0C for 3 hours.    The resultant mixture was warmed to room 
temperature and quenched with cold diethyl ether and extracted two times.    The combined 
organic phase was then washed with NaHCO, dried and concentrated to afford the crude product.    
This crude product was distilled to produce 5–bromo–penta–1,3–diene as a bright yellow oil at 
74 % yield.    1H NMR (250 MHz, CDCl3): δ 6.43–6.21 (m, 2H), 5.9–5.8 (m, 1H), 5.4–5.09 (m, 
2H), 4.04–4.01 m (d, J=7.6 Hz, 2H);    13C NMR (100 MHz, CDCl3): δ 135.5, 135.27, 129.09, 
119.43, 32.82. 
3–(tert–Butyl–dimethyl–silanyloxy)–propionaldehyde (3.4).    PCC (19.49g, 90.46 
mmol, 1.5 equiv.) and Al2O3 (19.49g) were both added to a flask equipped with a stir-bar that 
was purged by vacuum and flushed with nitrogen.    To this mixture, DCM was syringed into the 
flask and stirred at room temperature for a few minutes.    3–(tert–Butyl–dimethyl–silanyloxy)–
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propan–1–ol, 3.3, (11.48g, 60.31 mmol, 1 equiv.) in DCM was cannulated into the flask 
containing the PCC and Al2O3 and stirred at room temperature for approximately 2–3 hours.    
Diethyl ether was added to the reaction mixture and it was concentrated to remove the DCM/ 
ether.    The product was purified using all of the oxidized brown compound and flash 
chromatography (silica gel: pentane/ diethyl ether (9:1)) to produce a clear yellow oil in a 77 % 
yield.    1H NMR (250 MHz, CDCl3): δ 9.79 (s, 1H), 3.98 (t, J=6.05 Hz, 2H), 2.59 (t, J=2.1 Hz, 
2H), 0.88 (s, 9H), 0.06 (s, 6H);    13C NMR (100 MHz, CDCl3): δ 58.77, 57.39, 46.54, 37.39, 
25.79, – 5.45. 
1–(tert–Butyl–dimethyl–silanyloxy)–4–vinyl–hex–5–en–3–ol (3.5).     Indium powder 
(5.36g, 46.72 mmol, 1 equiv.) was added to a round bottom flask equipped with a stir-bar, 
purged by vacuum and filled with nitrogen.    To this flask, 3–(tert–Butyl–dimethyl–silanyloxy)–
propionaldehyde, 3.4, (8.8g, 46.72 mmol, 1 equiv.) in DMF was added and stirred for a few 
minutes.    5–Bromo–penta–1,3–diene, 3.2, (13.74g, 93.45 mmol, 2 equiv.) in DMF was added to 
the reaction mixture and it was stirred at 0 0C for three hours.    The mixture was quenched with 
1N HCl and extracted using diethyl ether.    It was washed using brine and dried using sodium 
sulfate.    It was column chromatographed (silica gel: pentane/ diethyl ether (95:05)) and 
concentrated to produce a light clear yellow oil at 86 % yield.    1H NMR (250 MHz, CDCl3): δ 
5.9–5.78 (m, 1H), 5.16–5.08 (m, 2H), 3.82–3.77 (m, 2H), 1.7–1.61 (m, 2H), 0.89 (s, 9H), 0.06 (s, 
6H);    13C NMR (100 MHz, CDCl3): δ 137.81, 137.36, 116.73, 116.5, 73.64, 62.58, 54.74, 
35.89, 25.86, 18.14, – 5.55. 
Methanesulfonic acid 1–[2–(tert–Butyl–dimethyl–silanyloxy)–ethyl]–2–vinyl–but–3–
enyl ester (3.6).    1–(tert–Butyl–dimethyl–silanyloxy)–4–vinyl–hex–5–en–3–ol, 3.5, (16.15g, 
63.47 mmol, 1 eqiuv.) was cannulated into a round bottom flask equipped with a stir-bar and 
dichloromethane.    NEt3 (16.06g, 158.68 mmol, 2.5 equiv.) was syringed into the RBF 
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containing the starting material and it was stirred for a few minutes at room temperature.    The 
temperature was lowered to 0 0C; before MsCl (10.91g 95.21 mmol, 1.5 equiv., 7.4 mL) was 
syringed into the mixture and it was warmed to room temperature and stirred for 2 hours.    Et2O 
(800 mL) was added to the reaction and the organic layer was extracted three times.   The 
organic phase was then washed with NaHCO and brine and dried using anhydrous MgSO4.    The 
product was purified by flash chromatography (silica gel: hexane/ ethyl acetate (9:1)) and 
concentrated to make a dark yellow oil in 96 % yield.    1H NMR (400 MHz, CDCl3): δ 5.84–
5.73 (m, 1H), 5.23–5.15 (m, 2H), 3.73–3.69 (m, 2H), 3.02 (s, 3H), 1.89–1.81 (m, 2H), 0.89 (s, 
9H), –0.05 (s, 6H);    13C NMR (100 MHz, CDCl3): δ 135.57, 135.11, 118.48, 118.14, 82.17, 
58.65, 51.83, 38.44, 34.54, 25.86, 18.19, – 5.39. 
4–vinyl–hex–5–en–1–ol (3.7 a).    LAH (16.24g, 427.96 mmol, 7 equiv.) was added to a 
flask that was purged by vacuum and filled with nitrogen and equipped with a stir-bar.    The 
temperature was lowered to 0 0C before the methanesulfonic acid 1–[2–(tert–Butyl–dimethyl–
silanyloxy)–ethyl]–2–vinyl–but–3–enyl ester, 3.6, (20.33g, 61.14 mmol, 1 equiv.) in Et2O was 
cannulated into the mixture.    The reaction was allowed to warm up to room temperature and 
stirred overnight.    The reaction mixture was quenched slowly by adding water (225 mL) drop–
wise.    Cold diethyl ether (100 mL) was also added and the mixture was filtered through celite.    
The products were purified using flash chromatography (silica gel: pentane/ diethyl ether (8:2)) 
to produce two compounds.     The first compound was a dark clear yellow oil in a 19 % yield 
and identified to be tert–butyl–dimethyl–(4–vinyl–hex–5–enyloxy)–silane, 3.7 b, and the second 
compound was the a clear yellow oil in a 72 % yield and the desired compound.    Compound 3.7 
a:    1H NMR (400 MHz, CDCl3): δ 5.76–5.67 (m, 1H), 5.04–5 (m, 2H), 3.72–3.71 (m, 2H), 1.6–
1.5 (m, 2H), 1.49–1.47 (m, 2H);    13C NMR (100 MHz, CDCl3): δ 141.00, 114.42, 62.90, 47.61, 
30.42, 30.36.    Compound 3.7 b:    1H NMR (400 MHz, CDCl3): δ 5.76–5.67 (m, 1H), 5.03–4.98 
 74
(m, 2H), 3.61–3.58 (t, J=12.56 Hz, 2H), 1.54–1.5 (m, 2H), 1.47–1.43 (m, 2H), 0.89 (s, 9H), 0.04 
(s, 6H);    13C NMR (100 MHz, CDCl3): δ 141.21, 114.2, 63.08, 47.58, 30.52, 30.37, 25.96, 
18.34, – 5.28. 
4–vinyl–hex–5–enal (3.8)    PCC (9.76g, 45.3 mmol, 1.5 equiv.) and Al2O3 (9.76) were 
both added to a flask equipped with a stir-bar that was purged and flushed with nitrogen.    To 
this mixture, DCM was syringed into the flask and stirred at room temperature for a few minutes.    
4–vinyl–hex–5–en–1–ol, 3.7 a, (3.81g, 30.2 mmol, 1 equiv.) in DCM was cannulated into the 
flask containing the PCC and Al2O3 and stirred at room temperature for approximately 2–3 
hours.    Diethyl ether was added to the reaction mixture and it was concentrated to remove the 
DCM/ ether.    The product was purified using all of the oxidized brown compound and flash 
chromatography (silica gel: pentane/ diethyl ether (9:1)) to produce a clear yellow oil in a 33 % 
yield.    1H NMR (400 MHz, CDCl3): δ 9.78 (t, J=1.52 Hz, 1H), 5.73–5.65 (m, 1H), 5.06–5.02 
(m, 2H), 2.48–2.44 (m, 2H), 1.78–1.73 (m, 2H);    13C NMR (100 MHz, CDCl3): δ 202.18, 
140.10, 115.22, 47.16, 41.60, 26.32. 
4–vinyl–hexahydro–cyclopenta[b]furan–2–one (3.9).    4-vinyl-hex-5-enal, 3.8, (2.55g, 
20.37 mmol, 1 equiv.) was added to a pressure apparatus equipped with a stir-bar and pentane 
(40 mL).    Cp2Ti(PMe3)2 (6.73g, 20.37 mmol, 1 equiv.) was also added to the reaction mixture 
and stirred for a few minutes.    The apparatus was sealed in the glove box and removed shortly 
afterwards.    Carbon monoxide gas (40 psi.) was introduced into the apparatus and it was stirred 
at room temperature for 24 hours.    The reaction mixture was poured into a beaker with Et2O 
(100 mL) and stirred for several hours exposed to the air.    There was a color change from dark 
purple to mustard yellow and it was filtered through a silica gel plug to produce a 2.18g of a red–
orange oil that was the crude product.    The product was obtained by flash chromatography 
(silica gel: pentane/ diethyl ether (8:2)) as a dark yellow-orange clear oil in 48 % yield.    1HMR 
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(400 MHz, CDCl3): δ 5.72–5.66 (m, 1H), 5.07–5.03 (m, 2H), 5.00–4.95 (m, 1H), 2.76–2.7 (m, 
1H), 2.5–2.48 (d, J=7.04 Hz, 1H), 2.39–2.29 (m, 2H), 2.19–2.17 (m, 1H), 1.98–1.9 (m, 2–3H), 
1.53–1.48 (m, 1H);    13C NMR (62.8 MHz, CDCl3): δ 176.89, 139.32, 115.11, 85.78, 50.01, 
44.96, 34.14, 31.86, 31.32. 
2–Pent–2–enyl–3–vinyl–cyclopentanol (3.10).  A 1.5 M solution of DIBAL–H in 
toluene (9 mL, 13.01 mmol, 1.65 equiv.) was added to 4–vinyl–hexahydro–cyclopenta[b]furan–
2–one, 3.9, (1.2 g, 7.88 mmol, 1 equiv.) in THF (8.25 mL) at –78 0C.  After stirring for 3 h; 
methanol (7.2 mL) was added to the mixture and it was warmed to room temperature.  Saturated 
NH4Cl (22 mL), Et2O (108 mL) and saturated sodium potassium tartrate (108 mL) were added to 
the suspension and it was stirred for 15 minutes to break up the emulsion.    The aqueous phase 
was collected and it was extracted with Et2O (2 x 23 mL) and the organic phase was dried with 
MgSO4, filtered, and concentrated to produce the lactol as a crude clear oil at 2.09 g. 
To a mixture of Ph3+(CH2)2CH3Br- (6.11 g, 15.85 mmol, 2.01 equiv.) in THF (25 mL) at 0 0C 
was added to a solution of potassium tert–butoxide in THF (4.14 mL, 33.25 mmol, 4.22 equiv.).    
After 15 minutes a solution of the lactol (1.2 g, 7.88 mmol, 1 equiv.) in THF (25 mL) was added 
to the mixture.    Saturated KH2PO4 was added to the mixture after stirring for 2.5 h and it was 
warmed to room temperature.    The mixture was extracted using EtOAc (4 x 50 mL), dried over 
Na2SO4, filtered, and concentrated to produce 1.94 g of a pale yellow oil.    The crude oil was 
purified using flash column chromatography (silica gel: pentane/ diethyl ether (8:2)) to produce 
2–Pent–2–enyl–3–vinyl–cyclopentanol, 3.10, as a clear yellow oil in 19 % yield.    1H NMR (250 
MHz, CDCl3): δ 5.63–5.59 (m, 1H), 5.44–5.38 (m, 2H), 5.05–4.93 (m, 2H), 4.23 (s, 1H), 4.15–
4.07 (dd, J=7.15 Hz, 1H), 2.4–2.29 (m, ), 2.17–2.04 (m, 2H), 0.99–0.93 (t, J=15.05 Hz, 3H);    
13C NMR (62.8 MHz, CDCl3): δ 142.65, 132.95, 128.05, 114.7, 74.46, 47.59, 33.84, 30.29, 
25.36, 21.45, 20.99, 14.68. 
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3–(2–Hydroxyethyl)–2–pent–2–enyl–cyclopentanol (3.11).    2–Pent–2–enyl–3–vinyl–
cyclopentanol, 3.10, (.121g, .671 mmol, 1 equiv.) was added to a flask containing THF and a 
stir-bar.    9-BBN (2.89 mL) was syringed into the mixture at 0 0C and it was warmed to room 
temperature and stirred for 2.5 hours and an additional 9-BBN (.671 mL) was added to the 
mixture.    The reaction was checked by TLC for completion and it was stirred an additional 1 
hour.    The mixture was exposed to air and 3M NaOH (1.9 mL) was added and the temperature 
was then lowered to 0 0C and 30 % H2O2 (1.52 mL) was added dropwise.    The mixture was 
allowed to warm-up to room temperature and stirred an additional 1 hour.    Et2O (38 mL) was 
added to the reaction mixture and it was washed with both NaHCO3 (38 mL) and brine (38 mL) 
and dried over MgSO4.    The product was obtained by flash column chromatography (silica gel: 
pentane/ diethyl ether (9:1)) to produce a yellow clear oil at 88 % yield.    1H NMR (300 MHz, 
CDCl3): δ 5.73–5.61 (m, 1H), 5.41 (s, 2H), 5.04–4.95 (m, 2H), 4.24 (s, 1H), 2.39–2.36 (m, ), 
2.15–1.96 (m, ), 1.65–1.58 (m, ), 1.43–1.34 (m, ), 1.25–1.24 (m, ), 0.99–0.94 (t, J=7.47 Hz, 3H);    
13C NMR (62.8 MHz, CDCl3): δ 133.06, 128.17, 62.38, 52.01, 39.11, 36.74, 33.78, 27.85, 25.93, 
21.04, 14.66. 
(3–Oxo–2–pent–2–enyl–cyclopentyl)–acetic acid (3.12).    A solution containing CrO3 
(60.5 mg, 0.605 mmol, 3.77 equiv.) in 1.5M H2SO4 (0.967 mL, 0.145 mmol, 9.03 equiv.) was 
kept between 5–10 0C.    3–(2–Hydroxy–ethyl)–2–pent–2–enyl–cyclopentanol, 3.11, (31.8 mg, 
0.16 mmol, 1 equiv.) in acetone (1.93 mL) was added to the mixture and stirred for 6 hours at 
between 5–10 0C.    It was stirred an additional 2 hours at room temperature.    Et2O (1.45 mL) 
was added and the mixture was extracted in brine (3 x 1.45 mL).    The organic phase was 
concentrated and Et2O (0.96 mL) was added.    The mixture was extracted using 1M NaOH (2 x 
0.72 mL).    The basic extracts were acidified with 6M H2SO4 and back extracted in Et2O (3 x 
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0.72 mL).    The combined Et2O extracts were washed with water & brine and dried with MgSO4 
and concentrated to produce a pale yellow oil in 30 % yield as the crude product. 
(3–Oxo–2–pent–2–enyl–cyclopentyl)–acetic acid methyl ester (3.13).    To a solution 
of (3–Oxo–2–pent–2–enyl–cyclopentyl)–acetic acid, 3.12, (0.0219g, 1.04 mmol, 1 equivalent) 
and DBU (0.0186g, 0.122 mmol, 1.17 equivalents) in benzene (5.2 mL) was added iodomethane 
(0.0222g, 0.156 mmol, 1.5 equivalents) in benzene (1.73 mL) at an ice–bath temperature.    The 
reaction was stirred for 2 h at room temperature, poured into cold water (6 mL) and extracted 
with Et2O.    The organic phase was dried over MgSO4 and concentrated to produce the crude 
product.    The product was obtained by flash column chromatography (silica gel: hexane/ diethyl 
ether (5:1)) to produce a yellow clear oil at 60 % yield.    1H NMR (400 MHz, CDCl3): δ 5.45–
5.42 (m, 1H), 5.26–5.23 (m, 1H), 3.68 (s, 3H), 2.71–2.68 (m, 1H), 2.36–2.31 (m, 2H), 2.28–2.19 
(m, 2H), 2.14–2.12 (m, 1H), 2.04–2.02 (m, 3H) 1.89–1.87 (m, 1H), 1.51–1.45 (m, 1H), 0.96–
0.93 (t, J=15.04 Hz, 3H);    13C NMR (100 MHz, CDCl3): δ 218.79, 172.47, 134.04, 124.92, 
53.97, 51.53, 38.78, 37.99, 37.67, 27.18, 25.47, 20.55, 14.03. 
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4.1. Ligands other than Carbon Monoxide: Isonitriles NCR 
Gautier 1 and Hoffmann 2 both simultaneously discovered isocyanides in 1867.    These 
compounds had an offensive odor, but isocyanides were difficult to synthesize and it was not 
until the work of Ugi 3-7 that an easy way produce isocyanides became available.    Isocyanides 
are stronger σ donors that CO.8    Isocyanides are slightly weaker π–acceptors than CO.    Like 
CO, isocyanides and isonitriles both are able to do insertions into metal–carbon bonds (Scheme 
4.1).    RNC are better σ–donors because they can stabilize higher oxidation states.    The ability 
of RNC to stabilize higher oxidative states decreases as the number of CO ligands increase on 
the metal center.    When RNC ligands are coordinated to high–valent metal centers; there is an 
increase in the C–N stretching frequency on the coordination to the metal.    Conversely, when 
RNCs are attached to low oxidative metal centers; they cause the N–C stretching frequency to 
decrease on the coordination to the metal center.9 
 
4.1.1. Carbon Monosulfide, CS 
Carbon monosulfide is a compound that is isoelectronic to both carbon monoxide and 
isocyanides.10    It is made from photolysis, thermolysis, and or cold electrical discharge.    It is a 
highly reactive gaseous compound that is “short–lived”.    The amount of time that CS exists 
depends on several variable factors.    These factors include pressure, temperature, and the 
surface to volume ratio.    At high temperatures above – 160 0C and exposure to sunlight, CS 
























M = Ti or Zr






























Scheme 4.1. The CO & CNR insertion into M–C σ bond of allenals. 
4.2. Synthetic Reactions using NCR: Buchwald & Grossman 
Buchwald and Grossman produced iminocyclopentenes and cyclopentenenones from 
different substituted enynes utilizing a titanocene carbonylation with either CO or 
isocyanides.11,12    One enyne substrate was not able to produce the desired cyclopentenenone.    
Instead, the only compound that was obtained was the starting material.    When the same enyne 
was converted to the titanocycle; the compound was subjected to isonitrile insertion and 

















Scheme 4.2. The synthesis of iminocyclopentenes from 1,6–enynes. 
4.2.1. Vu’s Reaction 
Vu synthesized an azadiene complex from an enal substrate using a titanium catalyst and 
an isonitrile insertion.13    When acid was added to the azadiene complex; bicyclic lactol analogs 













Scheme 4.3. Synthesis of a bicyclic lactol. 
 
When the reaction is done in the absence of an acid and in the presence of air or I2; bicyclic 





air = 23 %
or
I2 = 12 %  
Scheme 4.4. The oxidation of the azadiene complex with air or Iodine. 
Vu also produced analogs of tetracyclic spiroketal compounds from azadiene complexes when 
















1.7: 1  
Scheme 4.5. Production of tetracyclic spiroketal compound 
4.2.2. Steve’s Reaction 
In chapter 2, it was reported that α–methylene–γ–butyrolactones cannot be produced 
from a titanacene mediated hetero Pauson–Khand reaction.    Based on Buchwald’s, 
Grossman’s12 and Vu’s13 research using isonitrile insertions, it was determined that the 
titanacene allenal macrocycles should be subjected to isonitrile insertions to create derivatives of 
tert–butyl–(3–methylene–hexahydro–cyclopenta[b]furan–2–ylidene)–amines.    This would later 
be followed by hydrolysis to produce the desired α–methylene–γ–butyrolactones.    The 





















Scheme 4.6. A proposed synthesis of α–methylene–γ–butyrolactones via isonitrile insertions. 
 
4.3. Discussion and Conclusion 
Since the titanium promoted cyclocarbonylation of allene aldehyde substrates failed to 
produce the desired α–methylene–γ–butyrolactones; it was decided to try and synthesize tert–
butyl–(3–methylene–hexahydro–cyclopenta[b]furan–2–ylidene)–amine analogs instead.    These 
analogs could later be hydrolyzed to the corresponding α–methylene–γ–butyrolactones.    To 
 83
accomplish this goal, it was first decided to create compound 4.1 from the isonitrile insertion into 














3 h, rt2.6 4.1  
Scheme 4.7. Proposed synthesis of substrate 4.1 from compound 2.6. 
The synthesis of compound 4.2 was attempted from the starting reagent 2.30.    In the end, both 
substrates 4.1 and 4.2 were not produced.    Scheme 4.8 shows the reaction scheme to create 




















Scheme 4.8. Production of compound 4.2 from starting material 2.30. 
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Figure A.53. 1H NMR (300 MHz, CDCl3) of compound 2.34 
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Figure B.15. 1H NMR (400 MHz, CDCl3) of Compound 3.9 
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